<!--

File produced by pipelineRunner package (for JATS 2 SCJATS with pipeline SCJATS)
At: 2025-05-23T15:14:54.366Z

Version        : 1.16.1
Last update    : 2024-08-27
Modified by    : dunnm

-->
<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Cardiovasc Res</journal-id><journal-id journal-id-type="iso-abbrev">Cardiovasc Res</journal-id><journal-id journal-id-type="publisher-id">cardiovascres</journal-id><journal-title-group><journal-title>Cardiovascular Research</journal-title></journal-title-group><issn pub-type="ppub">0008-6363</issn><issn pub-type="epub">1755-3245</issn><publisher><publisher-name>Oxford University Press</publisher-name><publisher-loc>UK</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39982773</article-id><article-id pub-id-type="pmc">PMC12101352</article-id>
<article-id pub-id-type="doi">10.1093/cvr/cvaf024</article-id><article-id pub-id-type="publisher-id">cvaf024</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group><subj-group subj-group-type="category-taxonomy-collection"><subject>AcademicSubjects/MED00200</subject></subj-group><subj-group subj-group-type="category-taxonomy-collection"><subject>Eurheartj/8</subject></subj-group></article-categories><title-group><article-title>Endothelial c-REL orchestrates atherosclerosis at regions of disturbed flow through crosstalk with TXNIP-p38 and non-canonical NF-&#x003ba;B pathways</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Tardajos Ayllon</surname><given-names>Blanca</given-names></name><aff>
<institution>William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London</institution>, <addr-line>London EC1M 6BQ</addr-line>, <country country="GB">UK</country></aff><aff>
<institution>School of Medicine and Population Health, INSIGNEO Institute, and the Bateson Centre, University of Sheffield</institution>, <addr-line>Sheffield</addr-line>, <country country="GB">UK</country></aff></contrib><contrib contrib-type="author"><name><surname>Bowden</surname><given-names>Neil</given-names></name><aff>
<institution>School of Medicine and Population Health, INSIGNEO Institute, and the Bateson Centre, University of Sheffield</institution>, <addr-line>Sheffield</addr-line>, <country country="GB">UK</country></aff></contrib><contrib contrib-type="author"><name><surname>Souilhol</surname><given-names>Celine</given-names></name><aff>
<institution>School of Medicine and Population Health, INSIGNEO Institute, and the Bateson Centre, University of Sheffield</institution>, <addr-line>Sheffield</addr-line>, <country country="GB">UK</country></aff></contrib><contrib contrib-type="author"><name><surname>Darwish</surname><given-names>Hazem</given-names></name><aff>
<institution>School of Medicine and Population Health, INSIGNEO Institute, and the Bateson Centre, University of Sheffield</institution>, <addr-line>Sheffield</addr-line>, <country country="GB">UK</country></aff></contrib><contrib contrib-type="author"><name><surname>Tian</surname><given-names>Siyu</given-names></name><aff>
<institution>William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London</institution>, <addr-line>London EC1M 6BQ</addr-line>, <country country="GB">UK</country></aff><aff>
<institution>School of Medicine and Population Health, INSIGNEO Institute, and the Bateson Centre, University of Sheffield</institution>, <addr-line>Sheffield</addr-line>, <country country="GB">UK</country></aff></contrib><contrib contrib-type="author"><name><surname>Duckworth</surname><given-names>Carrie</given-names></name><aff>
<institution>Department of Molecular and Clinical Cancer Medicine, Institute of Systems, Molecular and Integrative Biology, University of Liverpool</institution>, <addr-line>Liverpool</addr-line>, <country country="GB">UK</country></aff></contrib><contrib contrib-type="author"><name><surname>Pritchard</surname><given-names>David Mark</given-names></name><aff>
<institution>Department of Molecular and Clinical Cancer Medicine, Institute of Systems, Molecular and Integrative Biology, University of Liverpool</institution>, <addr-line>Liverpool</addr-line>, <country country="GB">UK</country></aff></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-5488-5217</contrib-id><name><surname>Xu</surname><given-names>Suowen</given-names></name><aff>
<institution>Department of Endocrinology, Institute of Endocrine and Metabolic Disease, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, Clinical Research Hospital of Chinese Academy of Sciences (Hefei), University of Science and Technology of China</institution>, <addr-line>Hefei</addr-line>, <country country="CN">China</country></aff></contrib><contrib contrib-type="author"><name><surname>Sayers</surname><given-names>Jon</given-names></name><aff>
<institution>School of Medicine and Population Health, INSIGNEO Institute, and the Bateson Centre, University of Sheffield</institution>, <addr-line>Sheffield</addr-line>, <country country="GB">UK</country></aff></contrib><contrib contrib-type="author"><name><surname>Francis</surname><given-names>Sheila</given-names></name><aff>
<institution>School of Medicine and Population Health, INSIGNEO Institute, and the Bateson Centre, University of Sheffield</institution>, <addr-line>Sheffield</addr-line>, <country country="GB">UK</country></aff></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-8835-1491</contrib-id><name><surname>Serbanovic-Canic</surname><given-names>Jovana</given-names></name><aff>
<institution>School of Medicine and Population Health, INSIGNEO Institute, and the Bateson Centre, University of Sheffield</institution>, <addr-line>Sheffield</addr-line>, <country country="GB">UK</country></aff></contrib><contrib contrib-type="author"><name><surname>Oakley</surname><given-names>Fiona</given-names></name><aff>
<institution>Bioscience Institute, Faculty of Medical Science, Newcastle University</institution>, <addr-line>Newcastle Upon Tyne</addr-line>, <country country="GB">UK</country></aff></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-7975-681X</contrib-id><name><surname>Evans</surname><given-names>Paul Charles</given-names></name><aff>
<institution>William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London</institution>, <addr-line>London EC1M 6BQ</addr-line>, <country country="GB">UK</country></aff><xref rid="cvaf024-cor1" ref-type="corresp"/><xref rid="FN01" ref-type="author-notes"/><!--paul.evans@qmul.ac.uk--></contrib></contrib-group><author-notes><corresp id="cvaf024-cor1">Corresponding author. William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK. Tel: +44 (0)20 7882 5555, Email: <email>paul.evans@qmul.ac.uk</email></corresp><fn id="FN01" fn-type="COI-statement"><p>
<bold>Conflict of interest:</bold> F.O. is a director shareholder and employee in Fibrofind Ltd. All other authors declare no conflicts of interest.</p></fn></author-notes><pub-date pub-type="collection"><month>4</month><year>2025</year></pub-date><pub-date pub-type="epub" iso-8601-date="2025-02-21"><day>21</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="pmc-release"><day>21</day><month>2</month><year>2025</year></pub-date><volume>121</volume><issue>5</issue><fpage>748</fpage><lpage>759</lpage><history><date date-type="received"><day>15</day><month>1</month><year>2024</year></date><date date-type="rev-recd"><day>31</day><month>10</month><year>2024</year></date><date date-type="accepted"><day>07</day><month>1</month><year>2025</year></date><date date-type="corrected-typeset"><day>27</day><month>2</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2025. Published by Oxford University Press on behalf of the European Society of Cardiology.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:href="cvaf024.pdf"/><abstract><title>Abstract</title><sec id="s1"><title>Aims</title><p>Atherosclerosis initiation at sites of disturbed blood flow involves heightened inflammation coupled to excessive endothelial cell (EC) proliferation. Here, we unveil the pivotal role of c-REL, a member of the NF-&#x003ba;B transcription factor family, in orchestrating these processes by driving dual pathological inflammatory and cell cycle pathways.</p></sec><sec id="s2"><title>Methods and results</title><p>Analysis of cultured EC and murine models revealed enrichment and activation of c-REL at atherosusceptible sites experiencing disturbed flow. Transcriptome analysis, extensively validated <italic toggle="yes">in vitro</italic> and <italic toggle="yes">in vivo</italic>, demonstrates that endothelial c-REL drives inflammation via a TXNIP-p38 MAP kinase signalling pathway and enhances proliferation through a non-canonical <italic toggle="yes">NFKB2</italic>-p21 pathway. Consistent with its pivotal role in EC pathology, genetic deletion of <italic toggle="yes">c-Rel</italic> in EC significantly reduces plaque burden in hypercholesterolaemic mice.</p></sec><sec id="s3"><title>Conclusion</title><p>These findings underscore the fundamental role of c-REL in endothelial responses to disturbed flow and highlight therapeutic targeting of endothelial c-REL as a potential strategy for atherosclerosis treatment.</p></sec></abstract><abstract abstract-type="graphical"><title>Graphical Abstract</title><p>
<fig position="anchor" id="cvaf024-cvaf024_ga"><label>Graphical Abstract</label><graphic xlink:href="cvaf024_ga" position="float"/></fig>
</p></abstract><kwd-group><kwd>c-REL</kwd><kwd>Shear stress</kwd><kwd>Endothelial</kwd><kwd>Atherosclerosis</kwd></kwd-group><funding-group><award-group award-type="grant"><funding-source>
<institution-wrap><institution>British Heart Foundation</institution><institution-id institution-id-type="DOI">10.13039/501100000274</institution-id></institution-wrap>
</funding-source><award-id>RG/13/1/30042</award-id><award-id>PG/18/63/33968</award-id></award-group><award-group award-type="grant"><funding-source>
<institution-wrap><institution>Medical Research Council</institution><institution-id institution-id-type="DOI">10.13039/501100000265</institution-id></institution-wrap>
</funding-source><award-id>MR/K0019494/1</award-id><award-id>MR/R023026/1</award-id></award-group></funding-group><counts><page-count count="12"/></counts></article-meta></front><body><p>
<bold>This manuscript was handled by Guest Editor Thomas F. L&#x000fc;scher. Time of primary review: 61 daysSee the editorial comment for this article &#x02018;It is all c-RELative: a new perspective for a member of the nuclear factor kappa B family', by J. O&#x02019;Connor Miranda <italic toggle="yes">et al</italic>., <ext-link xlink:href="https://doi.org/10.1093/cvr/cvaf053" ext-link-type="uri">https://doi.org/10.1093/cvr/cvaf053</ext-link>.</bold>
</p><sec id="cvaf024-s1"><label>1.</label><title>Introduction</title><p>Atherosclerosis, a major cause of mortality, manifests as a focal disease characterized by the accumulation of lipids and inflammatory cells within arterial walls. While systemic risk factors such as hypercholesterolaemia contribute to its onset, atherosclerosis primarily develops near arterial branches and bends exposed to disturbed blood flow.<sup><xref rid="cvaf024-B1" ref-type="bibr">1&#x02013;3</xref></sup> These haemodynamic conditions result in low wall shear stress (WSS), leading to vascular inflammation and heightened proliferation of endothelial cells (ECs).<sup><xref rid="cvaf024-B4" ref-type="bibr">4&#x02013;6</xref></sup> While basal EC proliferation is crucial for vascular repair, excessive proliferation at sites of low shear stress promotes atherosclerosis initiation by increasing arterial permeability to cholesterol-rich lipoproteins.<sup><xref rid="cvaf024-B7" ref-type="bibr">7</xref></sup></p><p>The NF-&#x003ba;B family of transcription factors comprises five subunits: RELA (<italic toggle="yes">RELA</italic>), RELB (<italic toggle="yes">RELB</italic>), c-REL (<italic toggle="yes">c-REL/REL</italic>), p105/p50 (<italic toggle="yes">NFKB1</italic>), and p100/p52 (<italic toggle="yes">NFKB2</italic>), which form active transcription factors through homo- or heterodimerization.<sup><xref rid="cvaf024-B8" ref-type="bibr">8</xref></sup> Extensive research has concentrated on the canonical NF-&#x003ba;B family member, RELA, in the context of atherosclerosis, revealing its regulatory influence on vascular cell function, inflammation, and immunity.<sup><xref rid="cvaf024-B9" ref-type="bibr">9</xref>,<xref rid="cvaf024-B10" ref-type="bibr">10</xref></sup> Mice with EC-specific deletion of <italic toggle="yes">RelA</italic> exhibit diminished atherosclerosis, underscoring its pivotal role in this disease. Our studies, along with others&#x02019;, show that ECs at atheroprone sites are predisposed to heightened activation of RELA,<sup><xref rid="cvaf024-B11" ref-type="bibr">11&#x02013;14</xref></sup> offering a mechanistic explanation for increased inflammation in these regions. Despite its significance, RELA functions as a &#x02018;double-edged sword&#x02019; in ECs, concurrently activating genes that drive inflammation and an anti-apoptotic transcriptional programme crucial for cell survival.<sup><xref rid="cvaf024-B15" ref-type="bibr">15&#x02013;17</xref></sup> Consequently, targeting RELA for anti-inflammatory therapy encounters cytotoxicity which limits its potential therapeutic use.</p><p>Despite the extensive research on RELA in EC activation, the NF-&#x003ba;B family member c-REL possesses distinct biology and is still predominantly unexplored in this context. Here, we identify a role of endothelial c-REL in promoting inflammation and EC proliferation at sites of low shear stress and delineate the involvement of this pathway in atherosclerosis. The mechanism involves thioredoxin-interacting protein (TXNIP)-p38 (<italic toggle="yes">MAPK14</italic>) signalling driving inflammation and a <italic toggle="yes">NFKB2</italic>-p21 pathway driving EC proliferation. Our findings identify endothelial c-REL as a promising therapeutic target, offering a novel strategy to enhance EC function and alleviate atherosclerosis.</p></sec><sec id="cvaf024-s2"><label>2.</label><title>Methods</title><sec id="cvaf024-s2.1"><label>2.1</label><title>Experimental animals</title><p>All animal care and experimental procedures conformed to the institution&#x02019;s ethical requirements, UK Home Office regulations, and guidelines from Directive 2010/63/EU of the European Parliament on the protection of animals used for scientific purposes. Animal care and experimental procedures were carried out under Project Licence P5395C858 issued by the UK Home Office. Male mice aged between 2 and 4 months were utilized for experiments. Animals were euthanized through anaesthetic overdose via intraperitoneal (IP) injection of sodium pentobarbital.</p><sec id="cvaf024-s2.1.1"><label>2.1.1</label><title>Transgenic mice</title><p>Mice with conditional deletion of <italic toggle="yes">c-Rel</italic> (<italic toggle="yes">Rel</italic>) in ECs (<italic toggle="yes">c-Rel<sup>ECKO</sup></italic>) were generated through the crossbreeding of <italic toggle="yes">c-Rel<sup>fl/fl</sup></italic> mice<sup><xref rid="cvaf024-B18" ref-type="bibr">18</xref></sup> kindly provided by Professor Ulf Klein (University of Leeds, UK) with <italic toggle="yes">Cdh5<sup>Cre&#x02212;ERT2</sup></italic> mice.<sup><xref rid="cvaf024-B19" ref-type="bibr">19</xref></sup> CRE activation was induced by IP administration of tamoxifen (Sigma) in corn oil for five consecutive days (2&#x02005;mg/mouse/day). Mice with constitutive deletion of <italic toggle="yes">c-Rel</italic> (<italic toggle="yes">c-Rel<sup>KO</sup></italic>)<sup><xref rid="cvaf024-B20" ref-type="bibr">20</xref></sup> or <italic toggle="yes">Nfkb2</italic> (<italic toggle="yes">Nfkb2<sup>KO</sup></italic>)<sup><xref rid="cvaf024-B21" ref-type="bibr">21</xref></sup> were analysed. All transgenic mice were maintained on a C57BL/6J background. Genotyping was performed using PCR primers listed in <xref rid="sup1" ref-type="supplementary-material">Supplementary material online</xref>, <italic toggle="yes"><xref rid="sup1" ref-type="supplementary-material">Table S1</xref></italic>. Two weeks after the first injection of tamoxifen, hypercholesterolaemia was induced by IP injection of adeno-associated virus carrying a gain-of-function mutated version of proprotein convertase subtilisin/kexin type 9 (rAAV8-D377Y-mPCSK9) gene (Vector Core, North Carolina), followed by a western diet (SDS UK, 829100) for 6 weeks, as previously detailed.<sup><xref rid="cvaf024-B22" ref-type="bibr">22</xref></sup></p></sec><sec id="cvaf024-s2.1.2"><label>2.1.2</label><title>Pharmacological inhibition of c-REL in hypercholesterolaemic mice</title><p>Hypercholesterolaemia was induced by IP injection of rAAV8-D377Y-mPCSK9 followed by a western diet for 6 weeks. From Weeks 3&#x02013;6, c-REL was inhibited pharmacologically in wild-type C57BL/6J mice by IP injections of IT603 (24&#x02005;mg/kg dissolved in 75% DMSO in 0.9% sodium chloride; three injections per week). Control mice received IP injections of 75% DMSO in 0.9% sodium chloride.</p></sec></sec><sec id="cvaf024-s2.2"><label>2.2</label><title>Analysis of atherosclerosis plaque</title><p>Following euthanasia and perfusion fixation with PBS and 4% paraformaldehyde (PFA), aortas were dissected, cleaned, and stained with Oil Red O (Sigma). Aortas were then imaged through a Stemi 2000 C microscope (Zeiss) using a Canon PowerShot A650 IS digital camera, and lesion areas were quantified using NIS elements analysis software (Nikon, NY).</p></sec><sec id="cvaf024-s2.3"><label>2.3</label><title>Plasma lipid measurements</title><p>Blood samples collected by terminal cardiac puncture were subjected to centrifugation to obtain plasma. Plasma cholesterol and triglyceride levels were measured using a COBAS analyser.</p></sec><sec id="cvaf024-s2.4"><label>2.4</label><title>
<italic toggle="yes">En face</italic> staining of murine endothelium</title><p>Expression levels of specific proteins in ECs at distinct locations of the murine aortic arch, inner curvature (low shear stress site) and outer curvature (high shear stress site), were assessed by <italic toggle="yes">en face</italic> staining.<sup><xref rid="cvaf024-B23" ref-type="bibr">23</xref></sup> Aortas of animals humanely killed by IP injection of pentobarbital were perfusion-fixed with 4% PFA and immunostained using specific antibodies (see <xref rid="sup1" ref-type="supplementary-material">Supplementary material online</xref>, <italic toggle="yes"><xref rid="sup1" ref-type="supplementary-material">Table S2</xref></italic>). Confocal microscopy (Olympus SZ1000 confocal inverted microscope) was utilized to visualize endothelial surfaces <italic toggle="yes">en face</italic>, and mean fluorescence intensities were quantified to determine protein expression levels.</p></sec><sec id="cvaf024-s2.5"><label>2.5</label><title>EC culture and exposure to WSS</title><p>Human umbilical vein ECs (HUVECs) were isolated from umbilical cords (Royal Hallamshire Hospital, Sheffield, UK; ethical approval REC 10/H1308/25) or purchased from PromoCell and were maintained in M199 growth medium supplemented with 20% (v/v) foetal bovine serum, 100&#x02005;&#x003bc;g/mL streptomycin, 100&#x02005;U/mL penicillin, 2.5&#x02005;&#x003bc;g/mL amphotericin B, 4&#x02005;mmol/L L-glutamine, 10&#x02005;U/mL heparin, and 30&#x02005;&#x003bc;g/mL EC growth supplement. Human coronary artery ECs (HCAECs) were obtained from PromoCell and cultured following the manufacturer&#x02019;s instructions in supplemented Endothelial Cell Growth Medium MV2. Cells were analysed from individual donors so that variation between individuals could be captured. Cells at passage 3&#x02013;6 were seeded onto gelatin-coated 6-well plates. When they reached confluency, they were exposed to flow using an orbital shaking platform (PSU-10i; Grant Bio) set at 210&#x02005;rpm in a 37&#x000b0;C cell culture incubator, which generates low tangential shear stress (4.8&#x02005;dyn/cm<sup>2</sup>) at the centre of the well and high uniform shear stress (11.1&#x02005;dyn/cm<sup>2</sup>) at the periphery. For RNA and protein expression analysis, cells were isolated from the centre (circular region, 5&#x02005;mm radius) or periphery (ring-shaped region, 8&#x02005;mm wide) of wells by scraping using a standardized template, which is based on the computational fluid dynamics model.<sup><xref rid="cvaf024-B24" ref-type="bibr">24</xref></sup></p></sec><sec id="cvaf024-s2.6"><label>2.6</label><title>Gene silencing</title><p>EC cultures were transfected with siRNA sequences targeting <italic toggle="yes">c-REL</italic> (StealthRNAi siRNA RELHSS109157, Thermo Fisher Scientific) or <italic toggle="yes">NFKB2</italic> (L-003918-00-0005, ON-TARGETplus siRNA, Dharmacon) using the Neon transfection system (Thermo Fisher Scientific; HUVEC) or Lipofectamine RNAiMAX transfection reagent (Thermo Fisher Scientific; HCAEC), following the manufacturer&#x02019;s instructions. Non-targeting scrambled sequences served as a control (D-001810-01-50 ON-TARGETplus Non-targeting siRNA, Dharmacon).</p></sec><sec id="cvaf024-s2.7"><label>2.7</label><title>Lentiviral-mediated gene expression</title><p>Plasmids expressing FLAG-tagged versions of c-REL, p38, and TXNIP were synthesized and sub-cloned into the pGenLenti vector (GenScript Biotech). To produce lentivirus, pGenLenti vectors containing <italic toggle="yes">c-REL</italic>, <italic toggle="yes">p38</italic>, or <italic toggle="yes">TXNIP</italic> cDNA were transfected into HEK/293T cells together with the second-generation lentiviral packaging plasmid (psPAX2; Addgene) and the envelope plasmid (pMD2.G; Addgene) and cultured in Opti-MEM medium using polyethyleneimine (PEI), at a PEI/DNA ratio of 3:1. Virus was collected from medium 48&#x02013;72&#x02005;h after transfection.</p></sec><sec id="cvaf024-s2.8"><label>2.8</label><title>Bulk RNA analysis and qRT-PCR</title><p>ECs were isolated from the centre of 4 wells of a 6-well plate and pooled prior to bulk RNA analysis. RNA was extracted using the RNeasy Mini Kit (74104, Qiagen) and reverse transcribed into cDNA using the iScript cDNA synthesis kit (1708891, Bio-Rad). Bulk RNA analysis was carried out using the Human Clariom&#x02122; S Assay (Affymetrix), and data were analysed using Transcriptome Analysis Console Software (Affymetrix). Functional enrichments for protein-coding genes with <italic toggle="yes">P</italic> &#x0003c; 0.05 and log2 fold change &#x0003e; 1.2 were calculated using DAVID Functional Annotation Bioinformatics Microarray Analysis Software<sup><xref rid="cvaf024-B25" ref-type="bibr">25</xref></sup> and Metascape Software.<sup><xref rid="cvaf024-B26" ref-type="bibr">26</xref></sup> ECs were isolated from the centre of 2 wells of a 6-well plate prior to qRT-PCR analysis with gene-specific primers (see <xref rid="sup1" ref-type="supplementary-material">Supplementary material online</xref>, <italic toggle="yes"><xref rid="sup1" ref-type="supplementary-material">Table S3</xref></italic>). Reactions were prepared using SsoAdvanced universal SYBR&#x000ae;Green supermix (172-5271, Bio-Rad) and following the manufacturer&#x02019;s instructions and were performed in triplicate. Expression values were normalized against the house-keeping gene <italic toggle="yes">HPRT</italic>. Data were pooled from at least three independent donors, and mean values were calculated with SEM.</p></sec><sec id="cvaf024-s2.9"><label>2.9</label><title>Immunofluorescent staining of cultured EC</title><p>ECs were fixed, permeabilized, and blocked with goat serum as described previously. They were incubated overnight with primary antibodies against PCNA or Ki67 (proliferation markers); Caspase3 (apoptosis marker); p21, p53, or H2AX (senescence markers); and NF-&#x003ba;B subunits (see <xref rid="sup1" ref-type="supplementary-material">Supplementary material online</xref>, <italic toggle="yes"><xref rid="sup1" ref-type="supplementary-material">Table S2</xref></italic>) and Alexa Fluor 488 or 568-conjugated secondary antibodies. Nuclei were identified using DAPI (Sigma). Images were taken with a widefield fluorescence microscope (LeicaDMI4000B) and analysed using ImageJ software (1.49p) to calculate the frequency of positive cells. Isotype controls or omission of the primary antibody was used to control for non-specific staining.</p></sec><sec id="cvaf024-s2.10"><label>2.10</label><title>Immunoblotting</title><p>Total cell lysates were prepared using lysis buffer, and immunoblotting was conducted using specified primary antibodies (see <xref rid="sup1" ref-type="supplementary-material">Supplementary material online</xref>, <italic toggle="yes"><xref rid="sup1" ref-type="supplementary-material">Table S2</xref></italic>) and horseradish peroxidase&#x02013;conjugated secondary antibodies. Chemiluminescent detection was performed using ECL Prime&#x000ae; (GE Healthcare), and membranes were imaged with the Gel Doc XR + system (Bio-Rad). Alternatively, membranes were exposed to film (GE Healthcare) in a dark room, and the film was developed using developing solution (Ilford PQ Universal) and fixed with Ilford Hypam fixer.</p></sec><sec id="cvaf024-s2.11"><label>2.11</label><title>Generation of purified c-REL</title><p>Human <italic toggle="yes">c-REL</italic> cDNA (NP_002899.1) was cloned into the pET-21a(+) expression vector using standard restriction enzyme cloning techniques. <italic toggle="yes">Escherichia coli</italic> [BL21(DE3)] containing pET-21a(+)-<italic toggle="yes">c-REL</italic> were cultured using autoinduction LB media at 20&#x000b0;C with shaking for 36&#x02005;h. Bacterial pellets were collected and lysed in Tris-HCl buffer (pH 7) containing lysozyme followed by sonication. The recombinant c-REL protein was purified from the bacterial lysate through ion exchange followed by gel filtration chromatography.</p></sec><sec id="cvaf024-s2.12"><label>2.12</label><title>Electrophoretic mobility shift assay</title><p>A fluorescent (3&#x02032;-ATTO488) double-stranded probe corresponding to the consensus DNA binding sequence of c-REL (<italic toggle="yes">c-REL</italic> consensus probe) was prepared by annealing equimolar amounts of complementary DNA strands. Binding reactions were conducted with 100&#x02005;nM purified c-REL in the presence or absence of 100&#x02005;nM fluorescently labelled <italic toggle="yes">c-REL</italic> consensus probe in 10&#x02005;mM Tris borate EDTA (pH 8.3), 10&#x02005;mM NaCl, 40&#x02005;mM KCl, 1&#x02005;mM MgCl2, 1&#x02005;mM DTT, and 0.2&#x02005;mg/mL acetylated BSA at room temperature for 20&#x02005;min. Competition assays were performed using various concentrations of unlabelled double-stranded DNA probes corresponding to putative c-REL binding sites or scrambled control sequences. The mobility of the protein&#x02013;DNA complexes was analysed by non-denaturing 6% polyacrylamide gel electrophoresis at 100&#x02005;V for 1&#x02005;h. Fluorescent probes were detected using the Bio-Rad Gel Doc&#x02122; EZ System.</p></sec><sec id="cvaf024-s2.13"><label>2.13</label><title>Liver histology</title><p>Formalin-fixed liver tissue was processed for haematoxylin-eosin staining and evaluated for lipid droplet content, microsteatosis, and macrosteatosis by bright-field microscopy.</p></sec><sec id="cvaf024-s2.14"><label>2.14</label><title>Statistical analysis</title><p>Data are presented as mean values &#x000b1; SEM. Statistical analyses were performed using GraphPad Prism software, with significance levels indicated as follows: *<italic toggle="yes">P</italic> &#x0003c; 0.05, **<italic toggle="yes">P</italic> &#x0003c; 0.01, ***<italic toggle="yes">P</italic> &#x0003c; 0.001, and ****<italic toggle="yes">P</italic> &#x0003c; 0.0001. The specific test used is detailed in the figure legend.</p></sec></sec><sec id="cvaf024-s3"><label>3.</label><title>Results</title><sec id="cvaf024-s3.1"><label>3.1</label><title>Enrichment of c-REL at atherosusceptible sites by EC response to low shear stress</title><p>Analysis of publicly available single-cell RNAseq data revealed that c-Rel is expressed ubiquitously in multiple vascular cell types and immune cells in the murine aorta (see <xref rid="sup1" ref-type="supplementary-material">Supplementary material online</xref>, <italic toggle="yes"><xref rid="sup1" ref-type="supplementary-material">Figure S1</xref></italic>).<sup><xref rid="cvaf024-B27" ref-type="bibr">27</xref>,<xref rid="cvaf024-B28" ref-type="bibr">28</xref></sup> Focusing on endothelium, we investigated the potential correlation between shear stress and c-REL distribution by performing <italic toggle="yes">en face</italic> staining of murine aortic arch regions characterized by distinct shear stress profiles, as previously described.<sup><xref rid="cvaf024-B29" ref-type="bibr">29</xref></sup> Strikingly, our analysis revealed heightened levels of both total c-REL and nuclear c-REL at the inner curvature of the aortic arch (low shear stress; atherosusceptible site) compared to the outer curvature (high shear stress; atheroprotected) (<italic toggle="yes">Figure <xref rid="cvaf024-F1" ref-type="fig">1</xref>A</italic>). To ensure staining specificity, we conducted parallel experiments in <italic toggle="yes">c-Rel<sup>KO</sup></italic> mice, demonstrating the abolition of the fluorescent signal (<italic toggle="yes">Figure <xref rid="cvaf024-F1" ref-type="fig">1</xref>A</italic>). <italic toggle="yes">In vitro</italic> investigations further supported the relationship between c-REL and shear stress. We observed a significant elevation in c-REL protein expression in both HUVEC and HCAEC exposed to low shear stress compared to high shear stress conditions (<italic toggle="yes">Figure <xref rid="cvaf024-F1" ref-type="fig">1</xref>B</italic> and <italic toggle="yes">C</italic>). Collectively, our results indicate that c-REL is induced by low shear stress, leading to its enrichment at atherosusceptible regions within arteries.</p><fig position="float" id="cvaf024-F1" fig-type="figure"><label>Figure 1</label><caption><p>c-Rel is enriched at atheroprone sites via upregulation by low shear stress. (<italic toggle="yes">A</italic>) Aortic arches were isolated from control wild-type mice or from c<italic toggle="yes">-Rel<sup>KO</sup></italic> mice, and <italic toggle="yes">en face</italic> immunostainings were performed using anti-c-REL antibodies. The endothelium was stained with anti-CD31 antibodies and co-stained with TOPRO-3 (DNA). Representative images are shown (scale bar = 10&#x02005;&#x003bc;m). Each value in the graphs below represent the average nuclear (left) and whole-cell (right) c-REL mean fluorescence intensity (MFI) from 4 to 6 fields of view (10 cells quantified per field of view) from high or low shear stress regions of an individual control mouse (<italic toggle="yes">n</italic> = 5 mice) minus the MFI from c<italic toggle="yes">-Rel<sup>KO</sup></italic> (<italic toggle="yes">n</italic> = 5 mice) mice. (<italic toggle="yes">B</italic> and <italic toggle="yes">C</italic>) Human ECs were exposed to low or high shear stress for 72&#x02005;h using the orbital system. Levels of c-REL protein were analysed by immunoblotting with normalization to the level of PDHX in HUVEC (<italic toggle="yes">B</italic>) (<italic toggle="yes">n</italic> = 3 individual donors) or HCAEC (<italic toggle="yes">C</italic>) (<italic toggle="yes">n</italic> = 3 individual donors). Mean values are shown &#x000b1;standard errors. Differences between means were analysed using a paired <italic toggle="yes">t</italic>-test. *<italic toggle="yes">P</italic> &#x0003c; 0.05 and **<italic toggle="yes">P</italic> &#x0003c; 0.01.</p></caption><graphic xlink:href="cvaf024f1" position="float"/></fig></sec><sec id="cvaf024-s3.2"><label>3.2</label><title>c-REL co-ordinates endothelial inflammatory activation in response to low shear stress via TXNIP-p38 MAP kinase signalling</title><p>To elucidate the function of c-REL at atheroprone sites, we initially conducted bulk RNA analysis of HUVEC exposed to low shear stress and examined the impact of <italic toggle="yes">c-REL</italic> silencing on gene expression. Silencing of <italic toggle="yes">c-REL</italic> altered the expression of 2398 genes (1.2-fold; <italic toggle="yes">P</italic> &#x0003c; 0.05). Functional annotation using Metascape revealed multiple enriched Gene Ontology terms including those associated with inflammation (MAP kinase signalling, cellular response to cytokine stimulus, regulation of NF-&#x003ba;B signal transduction), cell proliferation (regulation of cell population proliferation, response to growth factor), and metabolism (protein catabolic process, mitochondrion organization, response to oxidative stress) (see <xref rid="sup1" ref-type="supplementary-material">Supplementary material online</xref>, <italic toggle="yes"><xref rid="sup1" ref-type="supplementary-material">Figure S2A</xref></italic>).</p><p>We validated the potential link to inflammation by analysing the effects of <italic toggle="yes">c-REL</italic> silencing in cultured human EC exposed to low shear stress. It was observed that silencing of <italic toggle="yes">c-REL</italic> led to a significant reduction in the expression of the inflammatory adhesion molecules VCAM1, ICAM1, and E-SELECTIN in HUVECs at both mRNA and protein levels (<italic toggle="yes">Figure <xref rid="cvaf024-F2" ref-type="fig">2</xref>A</italic> and <italic toggle="yes">B</italic>). Similarly, silencing of <italic toggle="yes">c-REL</italic> led to reduction in VCAM1, ICAM1, and E-SELECTIN in HCAECs exposed to low (<italic toggle="yes">Figure <xref rid="cvaf024-F2" ref-type="fig">2</xref>C</italic> and <italic toggle="yes">D</italic>) or high shear stress (see <xref rid="sup1" ref-type="supplementary-material">Supplementary material online</xref>, <italic toggle="yes"><xref rid="sup1" ref-type="supplementary-material">Figure S3A</xref></italic>). To further investigate the link between c-REL and inflammation, we recapitulated elevated c-REL in HCAEC exposed to low shear stress using a lentiviral system. This approach was validated by demonstrating enhanced levels of c-REL in cells transduced with lentiviral-c-REL compared to lentiviral control (see <xref rid="sup1" ref-type="supplementary-material">Supplementary material online</xref>, <italic toggle="yes"><xref rid="sup1" ref-type="supplementary-material">Figure S4A</xref></italic>). Overexpression of c-REL induced elevated levels of VCAM-1, ICAM-1, and E-SELECTIN at both mRNA and protein levels (see <xref rid="sup1" ref-type="supplementary-material">Supplementary material online</xref>, <italic toggle="yes"><xref rid="sup1" ref-type="supplementary-material">Figure S4B</xref></italic> and <italic toggle="yes"><xref rid="sup1" ref-type="supplementary-material">C</xref></italic>), confirming the regulation of adhesion molecule expression by c-REL. Consistent with these <italic toggle="yes">in vitro</italic> results, <italic toggle="yes">en face</italic> staining of the murine aorta demonstrated heightened VCAM-1, ICAM-1, and E-SELECTIN expression at low shear stress regions compared to high shear stress regions (<italic toggle="yes">Figure <xref rid="cvaf024-F2" ref-type="fig">2</xref>E&#x02013;G</italic>). Genetic deletion of <italic toggle="yes">c-Rel</italic> in mice significantly attenuated VCAM-1 (<italic toggle="yes">Figure <xref rid="cvaf024-F2" ref-type="fig">2</xref>E</italic>), ICAM-1 (<italic toggle="yes">Figure <xref rid="cvaf024-F2" ref-type="fig">2</xref>F</italic>), and E-SELECTIN (<italic toggle="yes">Figure <xref rid="cvaf024-F2" ref-type="fig">2</xref>G</italic>) expression at the low shear stress site, further supporting the role of c-REL as a positive regulator of inflammatory molecule expression.</p><fig position="float" id="cvaf024-F2" fig-type="figure"><label>Figure 2</label><caption><p>c-Rel promotes inflammation at atheroprone regions in response to low shear stress. (<italic toggle="yes">A&#x02013;D</italic>) Human ECs were treated with <italic toggle="yes">c-REL</italic> siRNA or with scrambled non-targeting sequences (SCRs) and exposed to low shear stress for 72&#x02005;h using the orbital system. Expression levels of <italic toggle="yes">c-REL</italic>, <italic toggle="yes">VCAM1</italic>, <italic toggle="yes">ICAM1</italic>, and <italic toggle="yes">E-SELECTIN</italic> were quantified by qRT-PCR in HUVEC (<italic toggle="yes">A</italic>) (<italic toggle="yes">n</italic> = 5 individual donors) and HCAEC (<italic toggle="yes">C</italic>) (<italic toggle="yes">n</italic> = 4 individual donors). Protein levels of VCAM1, ICAM1, and E-SELECTIN were analysed by immunoblotting and normalized to the level of PDHX in HUVEC (<italic toggle="yes">B</italic>) (<italic toggle="yes">n</italic> = 3 individual donors) and HCAEC (<italic toggle="yes">D</italic>) (<italic toggle="yes">n</italic> = 3 individual donors). (<italic toggle="yes">E&#x02013;G</italic>) EC inflammatory activation was analysed at low or high shear stress regions of the aorta in control (<italic toggle="yes">n</italic> = 5 mice) vs. <italic toggle="yes">c-Rel<sup>KO</sup></italic> (<italic toggle="yes">n</italic> = 5 mice) mice. <italic toggle="yes">En face</italic> immunostaining was performed using antibodies against VCAM1 (<italic toggle="yes">E</italic>), ICAM1 (<italic toggle="yes">F</italic>), or E-SELECTIN (<italic toggle="yes">G</italic>). ECs were identified using anti-CD31, and nuclei were co-stained with TOPRO-3. Representative images are shown (scale bar = 10&#x02005;&#x003bc;m). Each value represents the average MFI from 5 to 6 fields of view (10 cells analysed per field of view) from high or low shear stress regions of an individual mouse. Mean values are shown &#x000b1;standard errors. Differences between means were analysed using paired <italic toggle="yes">t</italic>-test (<italic toggle="yes">A&#x02013;D</italic>) or two-way ANOVA (<italic toggle="yes">E&#x02013;G</italic>). *<italic toggle="yes">P</italic> &#x0003c; 0.05, **<italic toggle="yes">P</italic> &#x0003c; 0.01, ***<italic toggle="yes">P</italic> &#x0003c; 0.001, and ****<italic toggle="yes">P</italic> &#x0003c; 0.0001.</p></caption><graphic xlink:href="cvaf024f2" position="float"/></fig><p>Our unbiased transcript analysis pinpointed c-REL as a key regulator of multiple MAPK pathways (see <xref rid="sup1" ref-type="supplementary-material">Supplementary material online</xref>, <italic toggle="yes"><xref rid="sup1" ref-type="supplementary-material">Figure S2B</xref></italic>), prompting us to hypothesize that MAPK regulation might underlie c-REL-driven endothelial activation. Consistent with this, silencing of <italic toggle="yes">c-REL</italic> led to a significant reduction in TXNIP, p38, and the TNF superfamily member RANK (<italic toggle="yes">TNFRSK11A</italic>) in HUVECs at both mRNA (<italic toggle="yes">Figure <xref rid="cvaf024-F3" ref-type="fig">3</xref>A</italic>) and protein (<italic toggle="yes">Figure <xref rid="cvaf024-F3" ref-type="fig">3</xref>B</italic>) levels. Similarly, silencing of c-REL led to reduction in TXNIP, P38, and RANK in HCAECs exposed to low (<italic toggle="yes">Figure <xref rid="cvaf024-F3" ref-type="fig">3</xref>C</italic> and <italic toggle="yes">D</italic>) or high (see <xref rid="sup1" ref-type="supplementary-material">Supplementary material online</xref>, <italic toggle="yes"><xref rid="sup1" ref-type="supplementary-material">Figure S3B</xref></italic>) shear stress. On the contrary, overexpression of c-REL induced elevated levels of TXNIP, p38, and RANK at both mRNA and protein levels (see <xref rid="sup1" ref-type="supplementary-material">Supplementary material online</xref>, <italic toggle="yes"><xref rid="sup1" ref-type="supplementary-material">Figure S4D</xref></italic> and <italic toggle="yes"><xref rid="sup1" ref-type="supplementary-material">E</xref></italic>). Interestingly, overexpression of p38 or TXNIP did not rescue inflammatory molecule expression in cells where c-REL was silenced (see <xref rid="sup1" ref-type="supplementary-material">Supplementary material online</xref>, <italic toggle="yes"><xref rid="sup1" ref-type="supplementary-material">Figure S5</xref></italic>). Our interpretation is that c-REL induces multiple signalling molecules each required for full inflammatory activation and that restoration of single members of this network is not sufficient to restore inflammation.</p><fig position="float" id="cvaf024-F3" fig-type="figure"><label>Figure 3</label><caption><p>c-Rel positively regulates pro-inflammatory MAP kinase signalling at low shear stress regions. (<italic toggle="yes">A&#x02013;D</italic>) Human ECs were treated with <italic toggle="yes">c-REL</italic> siRNA or with scrambled non-targeting sequences (SCR) and exposed to flow for 72&#x02005;h using the orbital system. ECs were isolated from the centre (low shear stress) of wells prior to qRT-PCR (<italic toggle="yes">A</italic> and <italic toggle="yes">C</italic>) or immunoblotting (<italic toggle="yes">B</italic> and <italic toggle="yes">D</italic>). Expression levels of <italic toggle="yes">TXNIP</italic>, <italic toggle="yes">p38</italic>, and <italic toggle="yes">RANK</italic> were quantified by qRT-PCR in HUVEC (<italic toggle="yes">A</italic>) (<italic toggle="yes">n</italic> = 5 individual donors) and HCAEC (<italic toggle="yes">C</italic>) (<italic toggle="yes">n</italic> = 4 individual donors). Protein levels of TXNIP, P38, and RANK were analysed by immunoblotting and normalized to the level of CALNEXIN or PDHX in HUVEC (<italic toggle="yes">B</italic>) (<italic toggle="yes">n</italic> = 3 individual donors) and HCAEC (<italic toggle="yes">D</italic>) (<italic toggle="yes">n</italic> = 3 individual donors). (<italic toggle="yes">E&#x02013;G</italic>) <italic toggle="yes">En face</italic> immunostaining was performed to quantify levels of TXNIP (<italic toggle="yes">E</italic>), P38 (<italic toggle="yes">F</italic>), and RANK (<italic toggle="yes">G</italic>) in EC at low or high shear stress regions of the aorta in control (<italic toggle="yes">n</italic> = 5 mice) vs. <italic toggle="yes">c-Rel</italic><sup>KO</sup> (<italic toggle="yes">n</italic> = 5 mice) mice. ECs were identified using anti-CD31, and nuclei were co-stained with TOPRO-3. Representative images are shown (scale bar = 10&#x02005;&#x003bc;m). Each value represents the average MFI from 5 to 6 fields of view (10 cells analysed per field of view) in high or low shear stress regions of each mouse. Mean values are shown &#x000b1;standard errors. Differences between means were analysed using paired <italic toggle="yes">t-</italic>tests (<italic toggle="yes">A&#x02013;D</italic>) or two-way ANOVA (<italic toggle="yes">E&#x02013;G</italic>). *<italic toggle="yes">P</italic> &#x0003c; 0.05, **<italic toggle="yes">P</italic> &#x0003c; 0.01, and ***<italic toggle="yes">P</italic> &#x0003c; 0.001.</p></caption><graphic xlink:href="cvaf024f3" position="float"/></fig><p>
<italic toggle="yes">In vitro</italic> findings were substantiated by <italic toggle="yes">en face</italic> staining of the murine aortic arch demonstrated heightened endothelial expression of TXNIP, p38, and RANK at the low shear stress region, with genetic deletion of <italic toggle="yes">c-Rel</italic> leading to reduced expression of each of these proteins (<italic toggle="yes">Figures <xref rid="cvaf024-F3" ref-type="fig">3</xref>E&#x02013;G</italic>). These data suggest that c-REL promotes inflammation at sites of low shear stress through augmentation of the p38 and its upstream regulators RANK and TXNIP.</p><p>To decipher the mechanism, we postulated that c-REL may induce an exogenous factor that drives inflammatory activation; however, transfer of cell culture medium from cultures where c-REL was silenced did not recapitulate the effects of c-REL silencing (see <xref rid="sup1" ref-type="supplementary-material">Supplementary material online</xref>, <italic toggle="yes"><xref rid="sup1" ref-type="supplementary-material">Figure S6</xref></italic>). We next investigated whether c-REL binds directly to the promoters of adhesion molecules and inflammatory MAP kinase components. Bioinformatics analysis revealed potential c-REL binding sites near the transcriptional start sites of <italic toggle="yes">VCAM-1</italic>, <italic toggle="yes">ICAM-1</italic>, <italic toggle="yes">E-selectin</italic>, <italic toggle="yes">P38</italic>, <italic toggle="yes">RANK</italic>, and <italic toggle="yes">TXNIP</italic> (see <xref rid="sup1" ref-type="supplementary-material">Supplementary material online</xref>, <italic toggle="yes"><xref rid="sup1" ref-type="supplementary-material">Figure S7</xref></italic>). Since high-quality antibodies for c-REL chromatin immunoprecipitation are unavailable, we analysed promoter binding empirically by electrophoretic mobility shift assay. The electrophoretic mobility of a <italic toggle="yes">c-REL</italic> consensus probe was retarded by purified c-REL (see <xref rid="sup1" ref-type="supplementary-material">Supplementary material online</xref>, <italic toggle="yes"><xref rid="sup1" ref-type="supplementary-material">Figure S8</xref></italic>). This retardation was reduced in a dose-dependent manner by probes corresponding to putative c-REL binding sites within <italic toggle="yes">VCAM-1</italic>, <italic toggle="yes">ICAM-1</italic>, <italic toggle="yes">E-SELECTIN</italic>, <italic toggle="yes">TXNIP</italic>, <italic toggle="yes">p38</italic>, and <italic toggle="yes">RANK</italic> but was not altered by scrambled control sequences (see <xref rid="sup1" ref-type="supplementary-material">Supplementary material online</xref>, <italic toggle="yes"><xref rid="sup1" ref-type="supplementary-material">Figure S8</xref></italic>), indicating interaction with each of the putative c-REL binding sequences. We conclude that c-REL is a driver of inflammatory activation in EC exposed to low shear stress conditions. The mechanism involves direct binding of c-REL to the promoters of genes encoding adhesion proteins and additionally involves the induction of pro-inflammatory MAP kinase signalling molecules.</p></sec><sec id="cvaf024-s3.3"><label>3.3</label><title>c-REL promotes EC proliferation in response to low shear stress via a non-canonical NF-&#x003ba;B pathways</title><p>We next explored the role of c-REL in EC proliferation. Gene silencing of <italic toggle="yes">c-REL</italic> resulted in a significant reduction in the percentage of proliferating HUVEC or HCAEC exposed to low shear stress, as indicated by the proportion of cells that expressed the markers PCNA (<italic toggle="yes">Figure <xref rid="cvaf024-F4" ref-type="fig">4</xref>A</italic> and <italic toggle="yes">B</italic>) and Ki67 (<italic toggle="yes">Figure <xref rid="cvaf024-F4" ref-type="fig">4</xref>C</italic> and <italic toggle="yes">D</italic>). Conversely, the impact of <italic toggle="yes">c-REL</italic> silencing in EC exposed to high shear stress was relatively modest (see <xref rid="sup1" ref-type="supplementary-material">Supplementary material online</xref>, <italic toggle="yes"><xref rid="sup1" ref-type="supplementary-material">Figure S9</xref></italic>). We obtained further evidence by overexpression of c-REL in HCAEC under low shear stress, which significantly elevated the proportion of cells that expressed PCNA and Ki67 (see <xref rid="sup1" ref-type="supplementary-material">Supplementary material online</xref>, <italic toggle="yes"><xref rid="sup1" ref-type="supplementary-material">Figure S10</xref></italic>). <italic toggle="yes">En face</italic> staining of Ki67 in the murine aorta consistently revealed enhanced EC proliferation in low shear stress conditions compared to high shear stress conditions (<italic toggle="yes">Figure <xref rid="cvaf024-F4" ref-type="fig">4</xref>E</italic>). Furthermore, genetic deletion of <italic toggle="yes">c-Rel</italic> significantly attenuated proliferation at low shear stress sites in the aorta (<italic toggle="yes">Figure <xref rid="cvaf024-F4" ref-type="fig">4</xref>E</italic>) suggesting that <italic toggle="yes">c-Rel</italic> contributes to augmented focal EC proliferation at sites of low shear stress.</p><fig position="float" id="cvaf024-F4" fig-type="figure"><label>Figure 4</label><caption><p>c-Rel promotes EC proliferation in response to low shear stress. (<italic toggle="yes">A&#x02013;D</italic>) Human ECs were treated with <italic toggle="yes">c-REL</italic> siRNA or with scrambled non-targeting sequences (SCR) and exposed to low shear stress for 72&#x02005;h using the orbital system. Proliferation was quantified by immunofluorescence staining using antibodies against PCNA (green) in HUVEC (<italic toggle="yes">A</italic>) (<italic toggle="yes">n</italic> = 3 individual donors) and in HCAEC (<italic toggle="yes">B</italic>) (<italic toggle="yes">n</italic> = 4 individual donors) and KI67 (green) in HUVEC (<italic toggle="yes">C</italic>) (<italic toggle="yes">n</italic> = 3 individual donors) and in HCAEC (<italic toggle="yes">D</italic>) (<italic toggle="yes">n</italic> = 3 individual donors). Each data point represents average values from 3 to 5 fields of view for each donor. Nuclei were co-stained with DAPI (blue) (scale bar = 50&#x02005;&#x003bc;m). (<italic toggle="yes">E</italic>) EC proliferation was analysed at low or high shear stress regions of the aorta in control (<italic toggle="yes">n</italic> = 5 mice) vs. <italic toggle="yes">c-Rel<sup>KO</sup></italic> (<italic toggle="yes">n</italic> = 5 mice) mice. <italic toggle="yes">En face</italic> immunostaining was performed using antibodies against Ki67. ECs were identified using anti-CD31, and nuclei were co-stained with TOPRO-3. Representative images are shown (scale bar = 10&#x02005;&#x003bc;m). The proportion of Ki67-positive cells was averaged from 5 to 7 fields of view in of high or low shear stress regions of each mouse. Mean values are shown &#x000b1;standard errors. Differences between means were analysed using paired <italic toggle="yes">t</italic>-tests (<italic toggle="yes">A</italic> and <italic toggle="yes">D</italic>) or two-way ANOVA (<italic toggle="yes">E</italic>). *<italic toggle="yes">P</italic> &#x0003c; 0.05, **<italic toggle="yes">P</italic> &#x0003c; 0.01, and ***<italic toggle="yes">P</italic> &#x0003c; 0.001.</p></caption><graphic xlink:href="cvaf024f4" position="float"/></fig><p>To decipher the mechanism, we initially analysed whether c-REL influences other members of the NF-&#x003ba;B family, which exhibit considerable cross-talk and play a pivotal role in proliferation.<sup><xref rid="cvaf024-B30" ref-type="bibr">30</xref></sup> qRT-PCR revealed that silencing of <italic toggle="yes">c-REL</italic> reduced mRNA levels of <italic toggle="yes">NFKB2</italic> but did not influence <italic toggle="yes">RELB</italic>, <italic toggle="yes">NFKB1</italic>, <italic toggle="yes">RELA</italic>, or the upstream NF-&#x003ba;B signalling molecules <italic toggle="yes">CHUK</italic>, <italic toggle="yes">IKBKB</italic>, <italic toggle="yes">IKBKG</italic>, or <italic toggle="yes">NFKB1A</italic> (see <xref rid="sup1" ref-type="supplementary-material">Supplementary material online</xref>, <italic toggle="yes"><xref rid="sup1" ref-type="supplementary-material">Figure S11A</xref></italic>). Similarly, immunofluorescent staining demonstrated that c-REL silencing led to a reduction in total and nuclear p52 levels but did not alter other NF-&#x003ba;B family members (see <xref rid="sup1" ref-type="supplementary-material">Supplementary material online</xref>, <italic toggle="yes"><xref rid="sup1" ref-type="supplementary-material">Figure S11B&#x02013;E</xref></italic>).</p><p>We next focused on the non-canonical NF-&#x003ba;B signalling pathway which acts upstream from <italic toggle="yes">NFKB2</italic>. This pathway is initiated through the activation of NF-&#x003ba;B-inducing kinase NIK (<italic toggle="yes">MAP3K14</italic>), which facilitates the proteolytic processing of p100 into p52, subsequently translocating to the nucleus. Immunoblotting revealed that low shear stress heightened the expression of p100 and the active p52 NF-&#x003ba;B subunit in HUVEC (<italic toggle="yes">Figure <xref rid="cvaf024-F5" ref-type="fig">5</xref>A</italic>) and HCAEC (<italic toggle="yes">Figure <xref rid="cvaf024-F5" ref-type="fig">5</xref>B</italic>). Moreover, <italic toggle="yes">c-REL</italic> silencing significantly attenuated the expression of both p100 and p52 in HUVEC (<italic toggle="yes">Figure <xref rid="cvaf024-F5" ref-type="fig">5</xref>C</italic>) and HCAEC (<italic toggle="yes">Figure <xref rid="cvaf024-F5" ref-type="fig">5</xref>D</italic>). Upstream from p100/p52, the expression of <italic toggle="yes">NIK</italic> was reduced by silencing of <italic toggle="yes">c-REL</italic> in HUVEC (<italic toggle="yes">Figure <xref rid="cvaf024-F5" ref-type="fig">5</xref>E</italic>) and HCAEC (<italic toggle="yes">Figure <xref rid="cvaf024-F5" ref-type="fig">5</xref>F</italic>). We concluded that <italic toggle="yes">c-REL</italic> can interact with a putative <italic toggle="yes">c-REL</italic> binding site within the promoter of <italic toggle="yes">NIK</italic> since a probe corresponding to this region competed for c-REL binding in an electrophoretic mobility shift assay (see <xref rid="sup1" ref-type="supplementary-material">Supplementary material online</xref>, <italic toggle="yes"><xref rid="sup1" ref-type="supplementary-material">Figure S8</xref></italic>). Consistently, <italic toggle="yes">en face</italic> staining of the murine aorta revealed enhanced expression of NIK at the low shear region and analysis of <italic toggle="yes">c-Rel<sup>KO</sup></italic> mice demonstrated that <italic toggle="yes">c-Rel</italic> was necessary for NIK enrichment at this site (<italic toggle="yes">Figure <xref rid="cvaf024-F5" ref-type="fig">5</xref>G</italic>).</p><fig position="float" id="cvaf024-F5" fig-type="figure"><label>Figure 5</label><caption><p>c-Rel enhances non-canonical NFKB2 activation in response to low shear stress. (<italic toggle="yes">A</italic> and <italic toggle="yes">B</italic>) Human ECs were exposed to low or high shear stress for 72&#x02005;h using the orbital system. (<italic toggle="yes">C</italic> and <italic toggle="yes">D</italic>) Human ECs were treated with <italic toggle="yes">c-REL</italic> siRNA or with scrambled non-targeting sequences (SCR) and exposed to low shear stress for 72&#x02005;h. (<italic toggle="yes">A&#x02013;D</italic>) Levels of the <italic toggle="yes">NFKB2</italic> gene products P100 and P52 were analysed by immunoblotting with normalization to the level of PDHX in HUVEC (<italic toggle="yes">A</italic> and <italic toggle="yes">C</italic>) (<italic toggle="yes">n</italic> = 3 individual donors) and HCAEC (<italic toggle="yes">B</italic> and <italic toggle="yes">D</italic>) (<italic toggle="yes">n</italic> = 3 individual donors). (<italic toggle="yes">E</italic> and <italic toggle="yes">F</italic>) Human ECs were treated with <italic toggle="yes">c-REL</italic> siRNA or with SCR and exposed to low shear stress for 72&#x02005;h. Expression levels of <italic toggle="yes">NIK</italic> were quantified by qRT-PCR in HUVEC (<italic toggle="yes">E</italic>) (<italic toggle="yes">n</italic> = 4 individual donors) and HCAEC (<italic toggle="yes">F</italic>) (<italic toggle="yes">n</italic> = 4 individual donors). (<italic toggle="yes">G</italic>) <italic toggle="yes">En face</italic> immunostaining was performed to quantify levels of NIK in EC at low or high shear stress regions of the aorta in control (<italic toggle="yes">n</italic> = 5 mice) vs. <italic toggle="yes">c-Rel<sup>KO</sup></italic> (<italic toggle="yes">n</italic> = 5 mice) mice. ECs were identified using anti-CD31, and nuclei were co-stained with TOPRO-3. Representative images are shown (scale bar = 10&#x02005;&#x003bc;m). Each value represents the average MFI from 5 to 6 fields of view (10 cells quantified per field of view) in high or low shear stress regions in each mouse. Mean values are shown &#x000b1;standard errors. Differences between means were analysed using paired <italic toggle="yes">t</italic>-tests (<italic toggle="yes">A&#x02013;F</italic>) or using two-way ANOVA (<italic toggle="yes">G</italic>). *<italic toggle="yes">P</italic> &#x0003c; 0.05, **<italic toggle="yes">P</italic> &#x0003c; 0.01, and ****<italic toggle="yes">P</italic> &#x0003c; 0.0001.</p></caption><graphic xlink:href="cvaf024f5" position="float"/></fig><p>We deduced that non-canonical NF-&#x003ba;B serves as a driver of EC proliferation because genetic deletion of <italic toggle="yes">NFKB2</italic> exhibited a trend towards reduced proliferation at low shear stress sites in the aorta (see <xref rid="sup1" ref-type="supplementary-material">Supplementary material online</xref>, <italic toggle="yes"><xref rid="sup1" ref-type="supplementary-material">Figure S12A</xref></italic>). Similarly silencing of <italic toggle="yes">NFKB2</italic> notably diminished the percentage of proliferating cells in HUVEC and HCAEC exposed to low shear stress conditions <italic toggle="yes">in vitro</italic> (see <xref rid="sup1" ref-type="supplementary-material">Supplementary material online</xref>, <italic toggle="yes"><xref rid="sup1" ref-type="supplementary-material">Figure S12B</xref></italic> and <italic toggle="yes"><xref rid="sup1" ref-type="supplementary-material">C</xref></italic>). At the mechanistic level, the expression of the cell cycle inhibitor p21 (<italic toggle="yes">CDKN1A</italic>) was enhanced by silencing of <italic toggle="yes">NFKB2</italic> (see <xref rid="sup1" ref-type="supplementary-material">Supplementary material online</xref>, <italic toggle="yes"><xref rid="sup1" ref-type="supplementary-material">Figure S12D&#x02013;G</xref></italic>) or <italic toggle="yes">c-REL</italic> (see <xref rid="sup1" ref-type="supplementary-material">Supplementary material online</xref>, <italic toggle="yes"><xref rid="sup1" ref-type="supplementary-material">Figure S12H</xref></italic> and <italic toggle="yes"><xref rid="sup1" ref-type="supplementary-material">I</xref></italic>) in HUVEC or HCAEC exposed to low shear stress. Collectively, these findings suggest that c-REL drives EC proliferation at sites of low shear stress by activating non-canonical NF-&#x003ba;B signalling to repress p21. Consistent with the role of p21 in senescence, we observed that <italic toggle="yes">c-REL</italic> silencing enhanced the expression of two markers of senescence, H2AX and p53, in HCAEC exposed to low shear stress (see <xref rid="sup1" ref-type="supplementary-material">Supplementary material online</xref>, <italic toggle="yes"><xref rid="sup1" ref-type="supplementary-material">Figure S13A</xref></italic> and <italic toggle="yes"><xref rid="sup1" ref-type="supplementary-material">B</xref></italic>). By contrast, <italic toggle="yes">c-REL</italic> silencing did not alter apoptosis in HCAEC and had relatively modest effects in HUVEC (see <xref rid="sup1" ref-type="supplementary-material">Supplementary material online</xref>, <italic toggle="yes"><xref rid="sup1" ref-type="supplementary-material">Figure S13C</xref></italic> and <italic toggle="yes"><xref rid="sup1" ref-type="supplementary-material">D</xref></italic>).</p></sec><sec id="cvaf024-s3.4"><label>3.4</label><title>Endothelial c-Rel promotes atherosclerosis</title><p>We hypothesized that c-REL may influence atherosclerosis given its pivotal role in regulating vascular inflammation. We initially analysed mice with whole-body <italic toggle="yes">c-Rel</italic> deletion (<italic toggle="yes">c-Rel<sup>KO</sup></italic>) which are viable and have a seemingly normal development, although they show a deficiency in lymphocyte proliferation and activation.<sup><xref rid="cvaf024-B31" ref-type="bibr">31</xref></sup> Administration of AAV-PCSK9 and exposure to a western diet for 6 weeks revealed a reduction in aortic atherosclerotic plaques in <italic toggle="yes">c-Rel<sup>KO</sup></italic> mice compared to controls (see <xref rid="sup1" ref-type="supplementary-material">Supplementary material online</xref>, <italic toggle="yes"><xref rid="sup1" ref-type="supplementary-material">Figure S14A</xref></italic>). Interestingly, plasma triglycerides and cholesterol levels were reduced in <italic toggle="yes">c-Rel<sup>KO</sup></italic> mice compared to controls (see <xref rid="sup1" ref-type="supplementary-material">Supplementary material online</xref>, <italic toggle="yes"><xref rid="sup1" ref-type="supplementary-material">Figure S14B</xref></italic>). To validate this result, we next assessed the influence of IT603, a pharmacological inhibitor of c-REL, on plasma lipid levels in hypercholesterolaemic mice. Mice were treated with AAV-PCSK9 and western diet for 6 weeks with concurrent treatment with IT603 from Weeks 3 to 6. Treatment with IT603 did not influence plaque size under this regime but significantly reduced plasma levels of LDL cholesterol (see <xref rid="sup1" ref-type="supplementary-material">Supplementary material online</xref>, <italic toggle="yes"><xref rid="sup1" ref-type="supplementary-material">Figure S15</xref></italic>). To begin to understand the mechanism linking <italic toggle="yes">c-Rel</italic> to plasma LDL cholesterol, we analysed whether <italic toggle="yes">c-Rel<sup>KO</sup></italic> mice exhibited alterations in liver steatosis or lipid regulators in hypercholesterolaemic mice. The degree of steatosis and frequency of lipid droplets in the liver was similar in <italic toggle="yes">c-Rel<sup>KO</sup></italic> mice and controls (see <xref rid="sup1" ref-type="supplementary-material">Supplementary material online</xref>, <italic toggle="yes"><xref rid="sup1" ref-type="supplementary-material">Figure S14C</xref></italic>). qRT-PCR was used to determine expression levels of multiple regulators of the cholesterol (<italic toggle="yes">Srebp2</italic>, <italic toggle="yes">Cyp51</italic>, <italic toggle="yes">Cyp7a1</italic>, <italic toggle="yes">Abca1</italic>) and triglyceride (<italic toggle="yes">Srebp1</italic>, <italic toggle="yes">Dgat2</italic>, <italic toggle="yes">Elov5</italic>, <italic toggle="yes">Elov6</italic>, <italic toggle="yes">Fabp1</italic>, <italic toggle="yes">Cd36</italic>) pathways. Livers from <italic toggle="yes">c-Rel<sup>KO</sup></italic> mice exhibited reduced expression levels of <italic toggle="yes">Abca1</italic>, <italic toggle="yes">Srebp2</italic>, and <italic toggle="yes">Elov6</italic> with a trend towards statistical significance (see <xref rid="sup1" ref-type="supplementary-material">Supplementary material online</xref>, <italic toggle="yes"><xref rid="sup1" ref-type="supplementary-material">Figure S14D</xref></italic>). We conclude that <italic toggle="yes">c-Rel</italic> regulates plasma cholesterol levels, possibly involving hepatic cholesterol metabolism.</p><p>Analysis of global c-REL knockout mice does not delineate the function of c-REL in EC vs. other cell types. Therefore, to specifically dissect the influence of endothelial c-REL on atherosclerosis, we selectively deleted <italic toggle="yes">c-Rel</italic> from the endothelium using the <italic toggle="yes">Cdh5<sup>CreERT2/+</sup></italic> line crossed with a <italic toggle="yes">c-Rel<sup>fl/fl</sup></italic> mouse, generating <italic toggle="yes">c-Rel<sup>ECKO</sup></italic> and control mice. Following AAV-PCSK9 treatment and exposure to a western diet for 8 weeks to induce hypercholesterolaemia, <italic toggle="yes">c-Rel<sup>ECKO</sup></italic> mice exhibited significantly smaller aortic atherosclerotic plaques compared to controls (<italic toggle="yes">Figure <xref rid="cvaf024-F6" ref-type="fig">6</xref>A</italic>), while plasma cholesterol and triglyceride levels remained unchanged (<italic toggle="yes">Figure <xref rid="cvaf024-F6" ref-type="fig">6</xref>B</italic>). These findings underscore endothelial <italic toggle="yes">c-Rel</italic> as a driver of atherosclerosis which is consistent with its ability to promote inflammation and endothelial turnover at atheroprone regions of the arterial tree.</p><fig position="float" id="cvaf024-F6" fig-type="figure"><label>Figure 6</label><caption><p>Endothelial c-Rel drives atherosclerosis. (<italic toggle="yes">A</italic> and <italic toggle="yes">B</italic>) <italic toggle="yes">c-Rel<sup>ECKO</sup></italic> mice (<italic toggle="yes">n</italic> = 8 mice) aged 9 weeks and littermates lacking <italic toggle="yes">Cre</italic> (controls; <italic toggle="yes">n</italic> = 7 mice) received five IP injections of tamoxifen and one injection of PCSK9-AAV virus 1 week later. Mice were fed with western for 6 weeks. (<italic toggle="yes">A</italic>) Representative images of aortas stained with Oil Red O (upper) and quantification of plaque burden by calculating the percentage of aortic surface area covered by plaque (lower) (scale bar = 2&#x02005;mm). (<italic toggle="yes">B</italic>) Total plasma cholesterol and triglyceride levels were measured and mean levels&#x000b1;standard errors are shown. Differences between means were analysed using an unpaired <italic toggle="yes">t</italic>-test. *<italic toggle="yes">P</italic> &#x0003c; 0.05, **<italic toggle="yes">P</italic> &#x0003c; 0.01, and ***<italic toggle="yes">P</italic> &#x0003c; 0.001.</p></caption><graphic xlink:href="cvaf024f6" position="float"/></fig><p>Collectively, these findings indicate that endothelial <italic toggle="yes">c-Rel</italic> promotes atherosclerosis by inducing pro-atherogenic inflammatory molecules at disease-prone regions. Moreover, targeting c-REL may offer a dual benefit of protecting the vasculature and lowering plasma lipoprotein levels to attenuate atherosclerosis.</p></sec></sec><sec id="cvaf024-s4"><label>4.</label><title>Discussion</title><p>The canonical NF-&#x003ba;B pathway controls multiple and diverse functions in many different tissues and cells. c-REL is traditionally known for its role in lymphocyte development,<sup><xref rid="cvaf024-B32" ref-type="bibr">32</xref></sup> but also plays a part in various pathologies, including inflammatory and autoimmune diseases,<sup><xref rid="cvaf024-B33" ref-type="bibr">33</xref></sup> fibrosis,<sup><xref rid="cvaf024-B20" ref-type="bibr">20</xref>,<xref rid="cvaf024-B34" ref-type="bibr">34</xref>,<xref rid="cvaf024-B35" ref-type="bibr">35</xref></sup> and cancer immunosurveillance.<sup><xref rid="cvaf024-B36" ref-type="bibr">36</xref></sup> Previous studies detected c-REL subunits in ECs and other cell types within human atherosclerotic plaques.<sup><xref rid="cvaf024-B9" ref-type="bibr">9</xref></sup> Despite this, the potential involvement of c-REL in atherosclerosis pathology has remained unexplored.</p><p>Here, we demonstrate that c-REL exhibits increased expression and nuclear localization in EC at sites of low shear stress which are predilection sites for atherogenesis. The mechanoreceptors and associated signalling pathways that enhance c-REL at sites of low shear stress are unknown. Several mechanosensitive pathways including PI3&#x02005;K, PKC&#x003b6;, and TGF-&#x003b2; signalling regulate post-translational modifications of c-REL in other contexts, and their potential role in c-REL activation at sites of low shear stress should be analysed in future studies.<sup><xref rid="cvaf024-B37" ref-type="bibr">37</xref>,<xref rid="cvaf024-B38" ref-type="bibr">38</xref></sup></p><p>Our research demonstrates that endothelial c-REL is a key regulator of inflammation and EC proliferation at sites of low shear stress. Inflammation is a pivotal factor in driving atherosclerosis, but the relationship between endothelial proliferation and atherosclerosis is intricate. EC proliferation is essential for vascular homeostasis; therefore, molecules suppressing basal proliferation have proatherogenic effects.<sup><xref rid="cvaf024-B23" ref-type="bibr">23</xref></sup> However, excessive EC proliferation can induce vascular leakiness as mitotic cells round up,<sup><xref rid="cvaf024-B7" ref-type="bibr">7</xref></sup> creating hot spots for lipoprotein influx from the circulation to the vessel wall, thereby promoting atherosclerosis. Notably, we found that genetic deletion of <italic toggle="yes">c-Rel</italic> in ECs results in a substantial reduction in inflammatory molecule expression and proliferation at sites of low shear stress coupled to reduced atherogenesis. This underscores that inflammation and proliferation driven by endothelial c-REL contribute to early atherosclerosis.</p><p>Our investigation of the mechanism of c-REL-driven inflammation involved an unbiased bulk RNA analysis where one of the most enriched Gene Ontology terms identified was MAP kinase signalling. Significantly, c-REL was found to regulate p38 and its upstream regulators RANK and TXNIP. This observation was substantiated through qPCR and immunoblotting in cultured cells using gene silencing and overexpression approaches and further confirmed <italic toggle="yes">in vivo</italic> by demonstrating reduced levels of p38, RANK, and TXNIP following <italic toggle="yes">c-Rel</italic> genetic deletion. Moreover, c-REL interacted with sequences corresponding to the promoters of these genes suggesting a potential transcriptional mechanism. Our findings align with the Berk lab, revealing TXNIP enrichment under disturbed flow and its pivotal role in p38 activation, crucial for adhesion protein expression and monocyte recruitment.<sup><xref rid="cvaf024-B5" ref-type="bibr">5</xref>,<xref rid="cvaf024-B39" ref-type="bibr">39</xref></sup> Additionally, we discovered that c-REL induces RANK, acting upstream of both the TXNIP-p38 and non-canonical NF-&#x003ba;B pathways.<sup><xref rid="cvaf024-B40" ref-type="bibr">40</xref>,<xref rid="cvaf024-B41" ref-type="bibr">41</xref></sup> While RANK is conventionally associated with bone physiology, its induction in angiogenic ECs suggests a vascular role.<sup><xref rid="cvaf024-B42" ref-type="bibr">42</xref></sup> Genetic studies linking RANK allelic variation to coronary artery disease in inflammatory vasculitis further support this.<sup><xref rid="cvaf024-B43" ref-type="bibr">43</xref></sup> Our data position c-REL as a novel player upstream in the RANK-TXNIP-p38 pathway, driving inflammation at atheroprone sites.</p><p>To define the mechanism linking c-REL to EC proliferation, we initially investigated crosstalk with other NF-&#x003ba;B family members since these drive proliferation in cancer cells and other contexts. We observed that c-REL specifically promotes non-canonical NF-&#x003ba;B2 activation by increasing the expression of p100, the precursor of the p52 NF-&#x003ba;B2 subunit, and by enhancing the expression of RANK and NIK which signal to promote p100 to p52 processing. The NIK-NF-&#x003ba;B2 pathway is recognized for driving cell proliferation in cancer by suppressing the expression of the cell cycle inhibitor p21.<sup><xref rid="cvaf024-B44" ref-type="bibr">44</xref></sup> We investigated whether this pathway is conserved in EC and demonstrated that c-REL-NFKB2 signalling represses p21 under low shear stress conditions. P21 is a central regulator of transient and irreversible forms of growth arrest such as senescence.<sup><xref rid="cvaf024-B45" ref-type="bibr">45</xref></sup> Intriguingly, c-REL suppressed markers of senescence in EC exposed to low shear stress. This suggests that c-REL may promote EC proliferation at sites of low shear stress, in part, by preventing irreversible growth arrest. Our observations do not rule out additional mechanisms linking c-REL to inflammatory activation or EC proliferation. Indeed, our unbiased bulk RNA analysis revealed c-REL regulation of metabolic and catabolic pathways and oxidative stress pathways that have clear links to inflammation and cell turnover.<sup><xref rid="cvaf024-B46" ref-type="bibr">46</xref>,<xref rid="cvaf024-B47" ref-type="bibr">47</xref></sup> Further work is needed to determine whether these pathways contribute to c-REL-driven EC phenotypic change and early atherogenesis.</p><p>Our group and others have previously shown that RELA contributes to arterial inflammation is sites of low shear stress.<sup><xref rid="cvaf024-B11" ref-type="bibr">11&#x02013;14</xref></sup> However, the function of RELA extends beyond inflammation through the induction of anti-apoptotic molecules that are essential for vascular viability.<sup><xref rid="cvaf024-B15" ref-type="bibr">15</xref>,<xref rid="cvaf024-B16" ref-type="bibr">16</xref></sup> This is apparent in mice with constitutive deletion of <italic toggle="yes">RelA</italic> which do not survive into adulthood due to the development of vascular damage associated with apoptosis.<sup><xref rid="cvaf024-B17" ref-type="bibr">17</xref></sup> In contrast, mice lacking <italic toggle="yes">c-Rel</italic> are viable<sup><xref rid="cvaf024-B20" ref-type="bibr">20</xref></sup> despite defects in myeloid and lymphoid immunity<sup><xref rid="cvaf024-B18" ref-type="bibr">18</xref>,<xref rid="cvaf024-B31" ref-type="bibr">31</xref>,<xref rid="cvaf024-B32" ref-type="bibr">32</xref>,<xref rid="cvaf024-B48" ref-type="bibr">48</xref></sup> that could potentially influence atherosclerosis. We explored the effects of global suppression of c-REL on atherosclerosis using two approaches: constitutive <italic toggle="yes">c-Rel</italic> deletion and pharmacological inhibition using IT603. Our analysis of constitutive <italic toggle="yes">c-Rel<sup>KO</sup></italic> mice confirmed an essential role in atherosclerosis, with noticeably smaller plaques. Intriguingly, constitutive <italic toggle="yes">c-Rel</italic> deletion and treatment with IT603 led to reduced plasma levels of plasma LDL cholesterol. <italic toggle="yes">c-Rel<sup>KO</sup></italic> mice also exhibited a trend towards altered expression of <italic toggle="yes">Srebp2</italic> and <italic toggle="yes">Abca1</italic>, which is consistent with previous research implicating c-REL in the control of liver metabolic pathways.<sup><xref rid="cvaf024-B49" ref-type="bibr">49</xref>,<xref rid="cvaf024-B50" ref-type="bibr">50</xref></sup> Further research is needed to clarify the mechanism linking c-REL to the regulation of plasma LDL cholesterol levels.</p><p>In summary, we show that endothelial c-REL orchestrates the initiation of atherosclerosis at sites of disturbed flow by activating a TXNIP-p38 pathway leading to inflammation and a NF-&#x003ba;B2-p21 pathway driving proliferation. Inhibition of c-REL provides a novel therapeutic strategy to enhance EC function and reduce atherosclerosis.</p></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material id="sup1" position="float" content-type="local-data"><label>cvaf024_Supplementary_Data</label><media xlink:href="cvaf024_supplementary_data.docx"/></supplementary-material></sec></body><back><sec id="cvaf024-s5"><title>Supplementary material</title><p>
<xref rid="sup1" ref-type="supplementary-material">Supplementary material</xref> is available at <italic toggle="yes">Cardiovascular Research</italic> online.</p></sec><sec id="cvaf024-s6"><title>Funding</title><p>P.C.E. was funded by the British Heart Foundation programme RG/13/1/30042 and project PG/18/63/33968 grants. F.O. received Medical Research Council funding, programme grants MR/K0019494/1 and MR/R023026/1.</p></sec><sec sec-type="data-availability"><title>Data availability</title><p>The data underlying this article are available in the article and in its online supplementary material.</p></sec><ref-list id="ref1"><title>References</title><ref id="cvaf024-B1"><label>1</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Kwak</surname> &#x000a0;<given-names>BR</given-names></string-name>, <string-name><surname>Back</surname> &#x000a0;<given-names>M</given-names></string-name>, <string-name><surname>Bochaton-Piallat</surname> &#x000a0;<given-names>ML</given-names></string-name>, <string-name><surname>Caligiuri</surname> &#x000a0;<given-names>G</given-names></string-name>, <string-name><surname>Daemens</surname> &#x000a0;<given-names>M</given-names></string-name>, <string-name><surname>Davies</surname> &#x000a0;<given-names>PF</given-names></string-name>, <string-name><surname>Hoefer</surname> &#x000a0;<given-names>IE</given-names></string-name>, <string-name><surname>Holvoet</surname> &#x000a0;<given-names>P</given-names></string-name>, <string-name><surname>Jo</surname> &#x000a0;<given-names>H</given-names></string-name>, <string-name><surname>Krams</surname> &#x000a0;<given-names>R</given-names></string-name>, <string-name><surname>Lehoux</surname> &#x000a0;<given-names>S</given-names></string-name>, <string-name><surname>Monaco</surname> &#x000a0;<given-names>C</given-names></string-name>, <string-name><surname>Steffens</surname> &#x000a0;<given-names>S</given-names></string-name>, <string-name><surname>Virmani</surname> &#x000a0;<given-names>R</given-names></string-name>, <string-name><surname>Weber</surname> &#x000a0;<given-names>C</given-names></string-name>, <string-name><surname>Wentzel</surname> &#x000a0;<given-names>JJ</given-names></string-name>, <string-name><surname>Evans</surname> &#x000a0;<given-names>PC</given-names></string-name></person-group>. <article-title>Biomechanical factors in atherosclerosis: mechanisms and clinical implications</article-title>. <source>Eur Heart J</source> &#x000a0;<year>2014</year>;<volume>35</volume>:<fpage>3013</fpage>&#x02013;<lpage>3020</lpage>.<pub-id pub-id-type="pmid">25230814</pub-id>
</mixed-citation></ref><ref id="cvaf024-B2"><label>2</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Brown</surname> &#x000a0;<given-names>AJ</given-names></string-name>, <string-name><surname>Teng</surname> &#x000a0;<given-names>ZZ</given-names></string-name>, <string-name><surname>Evans</surname> &#x000a0;<given-names>PC</given-names></string-name>, <string-name><surname>Gillard</surname> &#x000a0;<given-names>JH</given-names></string-name>, <string-name><surname>Samady</surname> &#x000a0;<given-names>H</given-names></string-name>, <string-name><surname>Bennett</surname> &#x000a0;<given-names>MR</given-names></string-name></person-group>. <article-title>Role of biomechanical forces in the natural history of coronary atherosclerosis</article-title>. <source>Nat Rev Cardiol</source> &#x000a0;<year>2016</year>;<volume>13</volume>:<fpage>210</fpage>&#x02013;<lpage>220</lpage>.<pub-id pub-id-type="pmid">26822720</pub-id>
</mixed-citation></ref><ref id="cvaf024-B3"><label>3</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Cavallero</surname> &#x000a0;<given-names>S</given-names></string-name>, <string-name><surname>Roustaei</surname> &#x000a0;<given-names>M</given-names></string-name>, <string-name><surname>Satta</surname> &#x000a0;<given-names>S</given-names></string-name>, <string-name><surname>Cho</surname> &#x000a0;<given-names>JM</given-names></string-name>, <string-name><surname>Phan</surname> &#x000a0;<given-names>H</given-names></string-name>, <string-name><surname>Baek</surname> &#x000a0;<given-names>KI</given-names></string-name>, <string-name><surname>Bl&#x000e1;zquez-Medela</surname> &#x000a0;<given-names>AM</given-names></string-name>, <string-name><surname>Gonzalez-Ramos</surname> &#x000a0;<given-names>S</given-names></string-name>, <string-name><surname>Vu</surname> &#x000a0;<given-names>K</given-names></string-name>, <string-name><surname>Park</surname> &#x000a0;<given-names>SK</given-names></string-name>, <string-name><surname>Yokota</surname> &#x000a0;<given-names>T</given-names></string-name>, <string-name><surname>Sumner</surname> &#x000a0;<given-names>JA</given-names></string-name>, <string-name><surname>Mack</surname> &#x000a0;<given-names>JJ</given-names></string-name>, <string-name><surname>Sigmund</surname> &#x000a0;<given-names>CD</given-names></string-name>, <string-name><surname>Reddy</surname> &#x000a0;<given-names>ST</given-names></string-name>, <string-name><surname>Li</surname> &#x000a0;<given-names>R</given-names></string-name>, <string-name><surname>Hsiai</surname> &#x000a0;<given-names>TK.</given-names></string-name></person-group> &#x000a0;<article-title>Exercise Mitigates Flow Recirculation and Activates Mechanosensitive Transcriptome to Uncover Endothelial SCD1-Catalyzed Anti-Inflammatory Metabolites</article-title>. <source>bioRxiv</source> &#x000a0;<year>2023</year>.</mixed-citation></ref><ref id="cvaf024-B4"><label>4</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Guo</surname> &#x000a0;<given-names>D</given-names></string-name>, <string-name><surname>Chien</surname> &#x000a0;<given-names>S</given-names></string-name>, <string-name><surname>Shyy</surname> &#x000a0;<given-names>JY</given-names></string-name></person-group>. <article-title>Regulation of endothelial cell cycle by laminar versus oscillatory flow&#x02014;distinct modes of interactions of AMP-activated protein kinase and Akt pathways</article-title>. <source>Circ Res</source> &#x000a0;<year>2007</year>;<volume>100</volume>:<fpage>564</fpage>&#x02013;<lpage>571</lpage>.<pub-id pub-id-type="pmid">17272808</pub-id>
</mixed-citation></ref><ref id="cvaf024-B5"><label>5</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Wang</surname> &#x000a0;<given-names>XQ</given-names></string-name>, <string-name><surname>Nigro</surname> &#x000a0;<given-names>P</given-names></string-name>, <string-name><surname>World</surname> &#x000a0;<given-names>C</given-names></string-name>, <string-name><surname>Fujiwara</surname> &#x000a0;<given-names>K</given-names></string-name>, <string-name><surname>Yan</surname> &#x000a0;<given-names>C</given-names></string-name>, <string-name><surname>Berk</surname> &#x000a0;<given-names>BC</given-names></string-name></person-group>. <article-title>Thioredoxin interacting protein promotes endothelial cell inflammation in response to disturbed flow by increasing leukocyte adhesion and repressing Kruppel-like factor 2</article-title>. <source>Circ Res</source> &#x000a0;<year>2012</year>;<volume>110</volume>:<fpage>560</fpage>&#x02013;<lpage>568</lpage>.<pub-id pub-id-type="pmid">22267843</pub-id>
</mixed-citation></ref><ref id="cvaf024-B6"><label>6</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Souilhol</surname> &#x000a0;<given-names>C</given-names></string-name>, <string-name><surname>Serbanovic-Canic</surname> &#x000a0;<given-names>J</given-names></string-name>, <string-name><surname>Fragiadaki</surname> &#x000a0;<given-names>M</given-names></string-name>, <string-name><surname>Chico</surname> &#x000a0;<given-names>TJ</given-names></string-name>, <string-name><surname>Ridger</surname> &#x000a0;<given-names>V</given-names></string-name>, <string-name><surname>Roddie</surname> &#x000a0;<given-names>H</given-names></string-name>, <string-name><surname>Evans</surname> &#x000a0;<given-names>PC</given-names></string-name></person-group>. <article-title>Endothelial responses to shear stress in atherosclerosis: a novel role for developmental genes</article-title>. <source>Nat Rev Cardiol</source> &#x000a0;<year>2020</year>;<volume>17</volume>:<fpage>52</fpage>&#x02013;<lpage>63</lpage>.<pub-id pub-id-type="pmid">31366922</pub-id>
</mixed-citation></ref><ref id="cvaf024-B7"><label>7</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Cancel</surname> &#x000a0;<given-names>LM</given-names></string-name>, <string-name><surname>Tarbell</surname> &#x000a0;<given-names>JM</given-names></string-name></person-group>. <article-title>The role of mitosis in LDL transport through cultured endothelial cell monolayers</article-title>. <source>Am J Physiol Heart Circ Physiol</source> &#x000a0;<year>2011</year>;<volume>300</volume>:<fpage>H769</fpage>&#x02013;<lpage>H776</lpage>.<pub-id pub-id-type="pmid">21169397</pub-id>
</mixed-citation></ref><ref id="cvaf024-B8"><label>8</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Van der Heiden</surname> &#x000a0;<given-names>K</given-names></string-name>, <string-name><surname>Cuhlmann</surname> &#x000a0;<given-names>S</given-names></string-name>, <string-name><surname>Luong</surname> &#x000a0;<given-names>LA</given-names></string-name>, <string-name><surname>Zakkar</surname> &#x000a0;<given-names>M</given-names></string-name>, <string-name><surname>Evans</surname> &#x000a0;<given-names>PC</given-names></string-name></person-group>. <article-title>Role of nuclear factor kappaB in cardiovascular health and disease</article-title>. <source>Clin Sci (Lond)</source> &#x000a0;<year>2010</year>;<volume>118</volume>:<fpage>593</fpage>&#x02013;<lpage>605</lpage>.<pub-id pub-id-type="pmid">20175746</pub-id>
</mixed-citation></ref><ref id="cvaf024-B9"><label>9</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Monaco</surname> &#x000a0;<given-names>C</given-names></string-name>, <string-name><surname>Andreakos</surname> &#x000a0;<given-names>E</given-names></string-name>, <string-name><surname>Kiriakidis</surname> &#x000a0;<given-names>S</given-names></string-name>, <string-name><surname>Mauri</surname> &#x000a0;<given-names>C</given-names></string-name>, <string-name><surname>Bicknell</surname> &#x000a0;<given-names>C</given-names></string-name>, <string-name><surname>Foxwell</surname> &#x000a0;<given-names>B</given-names></string-name>, <string-name><surname>Cheshire</surname> &#x000a0;<given-names>N</given-names></string-name>, <string-name><surname>Paleolog</surname> &#x000a0;<given-names>E</given-names></string-name>, <string-name><surname>Feldmann</surname> &#x000a0;<given-names>M</given-names></string-name></person-group>. <article-title>Canonical pathway of nuclear factor kappa B activation selectively regulates proinflammatory and prothrombotic responses in human atherosclerosis</article-title>. <source>Proc Natl Acad Sci U S A</source> &#x000a0;<year>2004</year>;<volume>101</volume>:<fpage>5634</fpage>&#x02013;<lpage>5639</lpage>.<pub-id pub-id-type="pmid">15064395</pub-id>
</mixed-citation></ref><ref id="cvaf024-B10"><label>10</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Gareus</surname> &#x000a0;<given-names>R</given-names></string-name>, <string-name><surname>Kotsaki</surname> &#x000a0;<given-names>E</given-names></string-name>, <string-name><surname>Xanthoulea</surname> &#x000a0;<given-names>S</given-names></string-name>, <string-name><surname>van der Made</surname> &#x000a0;<given-names>I</given-names></string-name>, <string-name><surname>Gijbels</surname> &#x000a0;<given-names>MJJ</given-names></string-name>, <string-name><surname>Kardakaris</surname> &#x000a0;<given-names>R</given-names></string-name>, <string-name><surname>Polykratis</surname> &#x000a0;<given-names>A</given-names></string-name>, <string-name><surname>Kollias</surname> &#x000a0;<given-names>G</given-names></string-name>, <string-name><surname>de Winther</surname> &#x000a0;<given-names>MPJ</given-names></string-name>, <string-name><surname>Pasparakis</surname> &#x000a0;<given-names>M</given-names></string-name></person-group>. <article-title>Endothelial cell-specific NF-kappa B inhibition protects mice from atherosclerosis</article-title>. <source>Cell Metab</source> &#x000a0;<year>2008</year>;<volume>8</volume>:<fpage>372</fpage>&#x02013;<lpage>383</lpage>.<pub-id pub-id-type="pmid">19046569</pub-id>
</mixed-citation></ref><ref id="cvaf024-B11"><label>11</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Cuhlmann</surname> &#x000a0;<given-names>S</given-names></string-name>, <string-name><surname>Van der Heiden</surname> &#x000a0;<given-names>K</given-names></string-name>, <string-name><surname>Saliba</surname> &#x000a0;<given-names>D</given-names></string-name>, <string-name><surname>Tremoleda</surname> &#x000a0;<given-names>JL</given-names></string-name>, <string-name><surname>Khalil</surname> &#x000a0;<given-names>M</given-names></string-name>, <string-name><surname>Zakkar</surname> &#x000a0;<given-names>M</given-names></string-name>, <string-name><surname>Chaudhury</surname> &#x000a0;<given-names>H</given-names></string-name>, <string-name><surname>Le</surname> &#x000a0;<given-names>AL</given-names></string-name>, <string-name><surname>Mason</surname> &#x000a0;<given-names>JC</given-names></string-name>, <string-name><surname>Udalova</surname> &#x000a0;<given-names>I</given-names></string-name>, <string-name><surname>Gsell</surname> &#x000a0;<given-names>W</given-names></string-name>, <string-name><surname>Jones</surname> &#x000a0;<given-names>H</given-names></string-name>, <string-name><surname>Haskard</surname> &#x000a0;<given-names>DO</given-names></string-name>, <string-name><surname>Krams</surname> &#x000a0;<given-names>R</given-names></string-name>, <string-name><surname>Evans</surname> &#x000a0;<given-names>PC</given-names></string-name></person-group>. <article-title>Disturbed blood flow induces RelA expression via c-Jun N-terminal kinase 1 A novel mode of NF-kappa B regulation that promotes arterial inflammation</article-title>. <source>Circ Res</source> &#x000a0;<year>2011</year>;<volume>108</volume>:<fpage>950</fpage>&#x02013;<lpage>959</lpage>.<pub-id pub-id-type="pmid">21350211</pub-id>
</mixed-citation></ref><ref id="cvaf024-B12"><label>12</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Nam</surname> &#x000a0;<given-names>D</given-names></string-name>, <string-name><surname>Ni</surname> &#x000a0;<given-names>C-W</given-names></string-name>, <string-name><surname>Rezvan</surname> &#x000a0;<given-names>A</given-names></string-name>, <string-name><surname>Suo</surname> &#x000a0;<given-names>J</given-names></string-name>, <string-name><surname>Budzyn</surname> &#x000a0;<given-names>K</given-names></string-name>, <string-name><surname>Llanos</surname> &#x000a0;<given-names>A</given-names></string-name>, <string-name><surname>Harrison</surname> &#x000a0;<given-names>D</given-names></string-name>, <string-name><surname>Giddens</surname> &#x000a0;<given-names>D</given-names></string-name>, <string-name><surname>Jo</surname> &#x000a0;<given-names>H</given-names></string-name></person-group>. <article-title>Partial carotid ligation is a model of acutely induced disturbed flow, leading to rapid endothelial dysfunction and atherosclerosis</article-title>. <source>Am J Physiol Heart Circ Physiol</source> &#x000a0;<year>2009</year>;<volume>297</volume>:<fpage>H1535</fpage>&#x02013;<lpage>H1543</lpage>.<pub-id pub-id-type="pmid">19684185</pub-id>
</mixed-citation></ref><ref id="cvaf024-B13"><label>13</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Hajra</surname> &#x000a0;<given-names>L</given-names></string-name>, <string-name><surname>Evans</surname> &#x000a0;<given-names>AI</given-names></string-name>, <string-name><surname>Chen</surname> &#x000a0;<given-names>M</given-names></string-name>, <string-name><surname>Hyduk</surname> &#x000a0;<given-names>SJ</given-names></string-name>, <string-name><surname>Collins</surname> &#x000a0;<given-names>T</given-names></string-name>, <string-name><surname>Cybulsky</surname> &#x000a0;<given-names>MI</given-names></string-name></person-group>. <article-title>The NF-kappa B signal transduction pathway in aortic endothelial cells is primed for activation in regions predisposed to atherosclerotic lesion formation</article-title>. <source>Proc Natl Acad Sci U S A</source> &#x000a0;<year>2000</year>;<volume>97</volume>:<fpage>9052</fpage>&#x02013;<lpage>9057</lpage>.<pub-id pub-id-type="pmid">10922059</pub-id>
</mixed-citation></ref><ref id="cvaf024-B14"><label>14</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Passerini</surname> &#x000a0;<given-names>AG</given-names></string-name>, <string-name><surname>Polacek</surname> &#x000a0;<given-names>DC</given-names></string-name>, <string-name><surname>Shi</surname> &#x000a0;<given-names>C</given-names></string-name>, <string-name><surname>Francesco</surname> &#x000a0;<given-names>NM</given-names></string-name>, <string-name><surname>Manduchi</surname> &#x000a0;<given-names>E</given-names></string-name>, <string-name><surname>Grant</surname> &#x000a0;<given-names>GR</given-names></string-name>, <string-name><surname>Pritchard</surname> &#x000a0;<given-names>WF</given-names></string-name>, <string-name><surname>Powell</surname> &#x000a0;<given-names>S</given-names></string-name>, <string-name><surname>Chang</surname> &#x000a0;<given-names>GY</given-names></string-name>, <string-name><surname>Stoeckert</surname> &#x000a0;<given-names>CJ</given-names></string-name>, <string-name><surname>Davies</surname> &#x000a0;<given-names>PF</given-names></string-name></person-group>. <article-title>Coexisting proinflammatory and antioxidative endothelial transcription profiles in a disturbed flow region of the adult porcine aorta</article-title>. <source>Proc Natl Acad Sci U S A</source> &#x000a0;<year>2004</year>;<volume>101</volume>:<fpage>2482</fpage>&#x02013;<lpage>2487</lpage>.<pub-id pub-id-type="pmid">14983035</pub-id>
</mixed-citation></ref><ref id="cvaf024-B15"><label>15</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Brouard</surname> &#x000a0;<given-names>S</given-names></string-name>, <string-name><surname>Berberat</surname> &#x000a0;<given-names>PO</given-names></string-name>, <string-name><surname>Tobiasch</surname> &#x000a0;<given-names>E</given-names></string-name>, <string-name><surname>Seldon</surname> &#x000a0;<given-names>MP</given-names></string-name>, <string-name><surname>Bach</surname> &#x000a0;<given-names>FH</given-names></string-name>, <string-name><surname>Soares</surname> &#x000a0;<given-names>MP</given-names></string-name></person-group>. <article-title>Heme oxygenase-1-derived carbon monoxide requires the activation of transcription factor NF-kappa B to protect endothelial cells from tumor necrosis factor-alpha-mediated apoptosis</article-title>. <source>J Biol Chem</source> &#x000a0;<year>2002</year>;<volume>277</volume>:<fpage>17950</fpage>&#x02013;<lpage>17961</lpage>.<pub-id pub-id-type="pmid">11880364</pub-id>
</mixed-citation></ref><ref id="cvaf024-B16"><label>16</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Partridge</surname> &#x000a0;<given-names>J</given-names></string-name>, <string-name><surname>Carlsen</surname> &#x000a0;<given-names>H</given-names></string-name>, <string-name><surname>Enesa</surname> &#x000a0;<given-names>K</given-names></string-name>, <string-name><surname>Chaudhury</surname> &#x000a0;<given-names>H</given-names></string-name>, <string-name><surname>Zakkar</surname> &#x000a0;<given-names>M</given-names></string-name>, <string-name><surname>Luong</surname> &#x000a0;<given-names>L</given-names></string-name>, <string-name><surname>Kinderlerer</surname> &#x000a0;<given-names>A</given-names></string-name>, <string-name><surname>Johns</surname> &#x000a0;<given-names>M</given-names></string-name>, <string-name><surname>Blomhoff</surname> &#x000a0;<given-names>R</given-names></string-name>, <string-name><surname>Mason</surname> &#x000a0;<given-names>JC</given-names></string-name>, <string-name><surname>Haskard</surname> &#x000a0;<given-names>DO</given-names></string-name>, <string-name><surname>Evans</surname> &#x000a0;<given-names>PC</given-names></string-name></person-group>. <article-title>Laminar shear stress acts as a switch to regulate divergent functions of NF-kappa B in endothelial cells</article-title>. <source>FASEB J</source> &#x000a0;<year>2007</year>;<volume>21</volume>:<fpage>3553</fpage>&#x02013;<lpage>3561</lpage>.<pub-id pub-id-type="pmid">17557931</pub-id>
</mixed-citation></ref><ref id="cvaf024-B17"><label>17</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Beg</surname> &#x000a0;<given-names>AA</given-names></string-name>, <string-name><surname>Sha</surname> &#x000a0;<given-names>WC</given-names></string-name>, <string-name><surname>Bronson</surname> &#x000a0;<given-names>RT</given-names></string-name>, <string-name><surname>Ghosh</surname> &#x000a0;<given-names>S</given-names></string-name>, <string-name><surname>Baltimore</surname> &#x000a0;<given-names>D</given-names></string-name></person-group>. <article-title>Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B</article-title>. <source>Nature</source> &#x000a0;<year>1995</year>;<volume>376</volume>:<fpage>167</fpage>&#x02013;<lpage>170</lpage>.<pub-id pub-id-type="pmid">7603567</pub-id>
</mixed-citation></ref><ref id="cvaf024-B18"><label>18</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Heise</surname> &#x000a0;<given-names>N</given-names></string-name>, <string-name><surname>De Silva</surname> &#x000a0;<given-names>NS</given-names></string-name>, <string-name><surname>Silva</surname> &#x000a0;<given-names>K</given-names></string-name>, <string-name><surname>Carette</surname> &#x000a0;<given-names>A</given-names></string-name>, <string-name><surname>Simonetti</surname> &#x000a0;<given-names>G</given-names></string-name>, <string-name><surname>Pasparakis</surname> &#x000a0;<given-names>M</given-names></string-name>, <string-name><surname>Klein</surname> &#x000a0;<given-names>U</given-names></string-name></person-group>. <article-title>Germinal center B cell maintenance and differentiation are controlled by distinct NF-&#x003ba;B transcription factor subunits</article-title>. <source>J Exp Med</source> &#x000a0;<year>2014</year>;<volume>211</volume>:<fpage>2103</fpage>&#x02013;<lpage>2118</lpage>.<pub-id pub-id-type="pmid">25180063</pub-id>
</mixed-citation></ref><ref id="cvaf024-B19"><label>19</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Wang</surname> &#x000a0;<given-names>Y</given-names></string-name>, <string-name><surname>Nakayama</surname> &#x000a0;<given-names>M</given-names></string-name>, <string-name><surname>Pitulescu</surname> &#x000a0;<given-names>ME</given-names></string-name>, <string-name><surname>Schmidt</surname> &#x000a0;<given-names>TS</given-names></string-name>, <string-name><surname>Bochenek</surname> &#x000a0;<given-names>ML</given-names></string-name>, <string-name><surname>Sakakibara</surname> &#x000a0;<given-names>A</given-names></string-name>, <string-name><surname>Adams</surname> &#x000a0;<given-names>S</given-names></string-name>, <string-name><surname>Davy</surname> &#x000a0;<given-names>A</given-names></string-name>, <string-name><surname>Deutsch</surname> &#x000a0;<given-names>U</given-names></string-name>, <string-name><surname>L&#x000fc;thi</surname> &#x000a0;<given-names>U</given-names></string-name>, <string-name><surname>Barberis</surname> &#x000a0;<given-names>A</given-names></string-name>, <string-name><surname>Benjamin</surname> &#x000a0;<given-names>LE</given-names></string-name>, <string-name><surname>M&#x000e4;kinen</surname> &#x000a0;<given-names>T</given-names></string-name>, <string-name><surname>Nobes</surname> &#x000a0;<given-names>CD</given-names></string-name>, <string-name><surname>Adams</surname> &#x000a0;<given-names>RH</given-names></string-name></person-group>. <article-title>Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis</article-title>. <source>Nature</source> &#x000a0;<year>2010</year>;<volume>465</volume>:<fpage>483</fpage>&#x02013;<lpage>486</lpage>.<pub-id pub-id-type="pmid">20445537</pub-id>
</mixed-citation></ref><ref id="cvaf024-B20"><label>20</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Fullard</surname> &#x000a0;<given-names>N</given-names></string-name>, <string-name><surname>Moles</surname> &#x000a0;<given-names>A</given-names></string-name>, <string-name><surname>O'Reilly</surname> &#x000a0;<given-names>S</given-names></string-name>, <string-name><surname>van Laar</surname> &#x000a0;<given-names>JM</given-names></string-name>, <string-name><surname>Faini</surname> &#x000a0;<given-names>D</given-names></string-name>, <string-name><surname>Diboll</surname> &#x000a0;<given-names>J</given-names></string-name>, <string-name><surname>Reynolds</surname> &#x000a0;<given-names>NJ</given-names></string-name>, <string-name><surname>Mann</surname> &#x000a0;<given-names>DA</given-names></string-name>, <string-name><surname>Reichelt</surname> &#x000a0;<given-names>J</given-names></string-name>, <string-name><surname>Oakley</surname> &#x000a0;<given-names>F</given-names></string-name></person-group>. <article-title>The c-Rel subunit of NF-kappa B regulates epidermal homeostasis and promotes skin fibrosis in mice</article-title>. <source>Am J Pathol</source> &#x000a0;<year>2013</year>;<volume>182</volume>:<fpage>2109</fpage>&#x02013;<lpage>2120</lpage>.<pub-id pub-id-type="pmid">23562440</pub-id>
</mixed-citation></ref><ref id="cvaf024-B21"><label>21</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Papoutsopoulou</surname> &#x000a0;<given-names>S</given-names></string-name>, <string-name><surname>Tang</surname> &#x000a0;<given-names>J</given-names></string-name>, <string-name><surname>Elramli</surname> &#x000a0;<given-names>AH</given-names></string-name>, <string-name><surname>Williams</surname> &#x000a0;<given-names>JM</given-names></string-name>, <string-name><surname>Gupta</surname> &#x000a0;<given-names>N</given-names></string-name>, <string-name><surname>Ikuomola</surname> &#x000a0;<given-names>FI</given-names></string-name>, <string-name><surname>Sheibani-Tezerji</surname> &#x000a0;<given-names>R</given-names></string-name>, <string-name><surname>Alam</surname> &#x000a0;<given-names>MT</given-names></string-name>, <string-name><surname>Hern&#x000e1;ndez-Fernaud</surname> &#x000a0;<given-names>JR</given-names></string-name>, <string-name><surname>Caama&#x000f1;o</surname> &#x000a0;<given-names>JH</given-names></string-name>, <string-name><surname>Probert</surname> &#x000a0;<given-names>CS</given-names></string-name>, <string-name><surname>Muller</surname> &#x000a0;<given-names>W</given-names></string-name>, <string-name><surname>Duckworth</surname> &#x000a0;<given-names>CA</given-names></string-name>, <string-name><surname>Pritchard</surname> &#x000a0;<given-names>DM</given-names></string-name></person-group>. <article-title>Nfkb2 deficiency and its impact on plasma cells and immunoglobulin expression in murine small intestinal mucosa</article-title>. <source>Am J Physiol Gastrointest Liver Physiol</source> &#x000a0;<year>2022</year>;<volume>323</volume>:<fpage>G306</fpage>&#x02013;<lpage>g317</lpage>.<pub-id pub-id-type="pmid">35916405</pub-id>
</mixed-citation></ref><ref id="cvaf024-B22"><label>22</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Bjorklund</surname> &#x000a0;<given-names>MM</given-names></string-name>, <string-name><surname>Hollensen</surname> &#x000a0;<given-names>AK</given-names></string-name>, <string-name><surname>Hagensen</surname> &#x000a0;<given-names>MK</given-names></string-name>, <string-name><surname>Dagnaes-Hansen</surname> &#x000a0;<given-names>F</given-names></string-name>, <string-name><surname>Christoffersen</surname> &#x000a0;<given-names>C</given-names></string-name>, <string-name><surname>Mikkelsen</surname> &#x000a0;<given-names>JG</given-names></string-name>, <string-name><surname>Bentzon</surname> &#x000a0;<given-names>JF</given-names></string-name></person-group>. <article-title>Induction of atherosclerosis in mice and hamsters without germline genetic engineering</article-title>. <source>Circ Res</source> &#x000a0;<year>2014</year>;<volume>114</volume>:<fpage>1684</fpage>&#x02013;<lpage>1689</lpage>.<pub-id pub-id-type="pmid">24677271</pub-id>
</mixed-citation></ref><ref id="cvaf024-B23"><label>23</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Souilhol</surname> &#x000a0;<given-names>C</given-names></string-name>, <string-name><surname>Ayllon</surname> &#x000a0;<given-names>BT</given-names></string-name>, <string-name><surname>Li</surname> &#x000a0;<given-names>XY</given-names></string-name>, <string-name><surname>Diagbouga</surname> &#x000a0;<given-names>MR</given-names></string-name>, <string-name><surname>Zhou</surname> &#x000a0;<given-names>ZQ</given-names></string-name>, <string-name><surname>Canham</surname> &#x000a0;<given-names>L</given-names></string-name>, <string-name><surname>Roddie</surname> &#x000a0;<given-names>H</given-names></string-name>, <string-name><surname>Pirri</surname> &#x000a0;<given-names>D</given-names></string-name>, <string-name><surname>Chambers</surname> &#x000a0;<given-names>EV</given-names></string-name>, <string-name><surname>Dunning</surname> &#x000a0;<given-names>MJ</given-names></string-name>, <string-name><surname>Ariaans</surname> &#x000a0;<given-names>M</given-names></string-name>, <string-name><surname>Li</surname> &#x000a0;<given-names>J</given-names></string-name>, <string-name><surname>Fang</surname> &#x000a0;<given-names>Y</given-names></string-name>, <string-name><surname>Jorgensen</surname> &#x000a0;<given-names>HF</given-names></string-name>, <string-name><surname>Simons</surname> &#x000a0;<given-names>M</given-names></string-name>, <string-name><surname>Krams</surname> &#x000a0;<given-names>R</given-names></string-name>, <string-name><surname>Waltenberger</surname> &#x000a0;<given-names>J</given-names></string-name>, <string-name><surname>Fragiadaki</surname> &#x000a0;<given-names>M</given-names></string-name>, <string-name><surname>Ridger</surname> &#x000a0;<given-names>V</given-names></string-name>, <string-name><surname>De Val</surname> &#x000a0;<given-names>S</given-names></string-name>, <string-name><surname>Francis</surname> &#x000a0;<given-names>SE</given-names></string-name>, <string-name><surname>Chico</surname> &#x000a0;<given-names>TJA</given-names></string-name>, <string-name><surname>Serbanovic-Canic</surname> &#x000a0;<given-names>J</given-names></string-name>, <string-name><surname>Evans</surname> &#x000a0;<given-names>PC</given-names></string-name></person-group>. <article-title>JAG1-NOTCH4 mechanosensing drives atherosclerosis</article-title>. <source>Sci Adv</source> &#x000a0;<year>2022</year>;<volume>8</volume>:<comment>eabo7958</comment>.</mixed-citation></ref><ref id="cvaf024-B24"><label>24</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Warboys</surname> &#x000a0;<given-names>CM</given-names></string-name>, <string-name><surname>de Luca</surname> &#x000a0;<given-names>A</given-names></string-name>, <string-name><surname>Amini</surname> &#x000a0;<given-names>N</given-names></string-name>, <string-name><surname>Luong</surname> &#x000a0;<given-names>L</given-names></string-name>, <string-name><surname>Duckles</surname> &#x000a0;<given-names>H</given-names></string-name>, <string-name><surname>Hsiao</surname> &#x000a0;<given-names>S</given-names></string-name>, <string-name><surname>White</surname> &#x000a0;<given-names>A</given-names></string-name>, <string-name><surname>Biswas</surname> &#x000a0;<given-names>S</given-names></string-name>, <string-name><surname>Khamis</surname> &#x000a0;<given-names>R</given-names></string-name>, <string-name><surname>Chong</surname> &#x000a0;<given-names>CK</given-names></string-name>, <string-name><surname>Cheung</surname> &#x000a0;<given-names>W-M</given-names></string-name>, <string-name><surname>Sherwin</surname> &#x000a0;<given-names>SJ</given-names></string-name>, <string-name><surname>Bennett</surname> &#x000a0;<given-names>MR</given-names></string-name>, <string-name><surname>Gil</surname> &#x000a0;<given-names>J</given-names></string-name>, <string-name><surname>Mason</surname> &#x000a0;<given-names>JC</given-names></string-name>, <string-name><surname>Haskard</surname> &#x000a0;<given-names>DO</given-names></string-name>, <string-name><surname>Evans</surname> &#x000a0;<given-names>PC</given-names></string-name></person-group>. <article-title>Disturbed flow promotes endothelial senescence via a p53-Dependent pathway</article-title>. <source>Arterioscler Thromb Vasc Biol</source> &#x000a0;<year>2014</year>;<volume>34</volume>:<fpage>985</fpage>&#x02013;<lpage>995</lpage>.<pub-id pub-id-type="pmid">24651677</pub-id>
</mixed-citation></ref><ref id="cvaf024-B25"><label>25</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Huang da</surname> &#x000a0;<given-names>W</given-names></string-name>, <string-name><surname>Sherman</surname> &#x000a0;<given-names>BT</given-names></string-name>, <string-name><surname>Lempicki</surname> &#x000a0;<given-names>RA</given-names></string-name></person-group>. <article-title>Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources</article-title>. <source>Nat Protoc</source> &#x000a0;<year>2009</year>;<volume>4</volume>:<fpage>44</fpage>&#x02013;<lpage>57</lpage>.<pub-id pub-id-type="pmid">19131956</pub-id>
</mixed-citation></ref><ref id="cvaf024-B26"><label>26</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Zhou</surname> &#x000a0;<given-names>Y</given-names></string-name>, <string-name><surname>Zhou</surname> &#x000a0;<given-names>B</given-names></string-name>, <string-name><surname>Pache</surname> &#x000a0;<given-names>L</given-names></string-name>, <string-name><surname>Chang</surname> &#x000a0;<given-names>M</given-names></string-name>, <string-name><surname>Khodabakhshi</surname> &#x000a0;<given-names>AH</given-names></string-name>, <string-name><surname>Tanaseichuk</surname> &#x000a0;<given-names>O</given-names></string-name>, <string-name><surname>Benner</surname> &#x000a0;<given-names>C</given-names></string-name>, <string-name><surname>Chanda</surname> &#x000a0;<given-names>SK</given-names></string-name></person-group>. <article-title>Metascape provides a biologist-oriented resource for the analysis of systems-level datasets</article-title>. <source>Nat Commun</source> &#x000a0;<year>2019</year>;<volume>10</volume>:<fpage>1523</fpage>.<pub-id pub-id-type="pmid">30944313</pub-id>
</mixed-citation></ref><ref id="cvaf024-B27"><label>27</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Kalluri</surname> &#x000a0;<given-names>AS</given-names></string-name>, <string-name><surname>Vellarikkal</surname> &#x000a0;<given-names>SK</given-names></string-name>, <string-name><surname>Edelman</surname> &#x000a0;<given-names>ER</given-names></string-name>, <string-name><surname>Nguyen</surname> &#x000a0;<given-names>L</given-names></string-name>, <string-name><surname>Subramanian</surname> &#x000a0;<given-names>A</given-names></string-name>, <string-name><surname>Ellinor</surname> &#x000a0;<given-names>PT</given-names></string-name>, <string-name><surname>Regev</surname> &#x000a0;<given-names>A</given-names></string-name>, <string-name><surname>Kathiresan</surname> &#x000a0;<given-names>S</given-names></string-name>, <string-name><surname>Gupta</surname> &#x000a0;<given-names>RM</given-names></string-name></person-group>. <article-title>Single-cell analysis of the normal mouse aorta reveals functionally distinct endothelial cell populations</article-title>. <source>Circulation</source> &#x000a0;<year>2019</year>;<volume>140</volume>:<fpage>147</fpage>&#x02013;<lpage>163</lpage>.<pub-id pub-id-type="pmid">31146585</pub-id>
</mixed-citation></ref><ref id="cvaf024-B28"><label>28</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Kan</surname> &#x000a0;<given-names>H</given-names></string-name>, <string-name><surname>Zhang</surname> &#x000a0;<given-names>K</given-names></string-name>, <string-name><surname>Mao</surname> &#x000a0;<given-names>A</given-names></string-name>, <string-name><surname>Geng</surname> &#x000a0;<given-names>L</given-names></string-name>, <string-name><surname>Gao</surname> &#x000a0;<given-names>M</given-names></string-name>, <string-name><surname>Feng</surname> &#x000a0;<given-names>L</given-names></string-name>, <string-name><surname>You</surname> &#x000a0;<given-names>Q</given-names></string-name>, <string-name><surname>Ma</surname> &#x000a0;<given-names>X</given-names></string-name></person-group>. <article-title>Single-cell transcriptome analysis reveals cellular heterogeneity in the ascending aortas of normal and high-fat diet-fed mice</article-title>. <source>Exp Mol Med</source> &#x000a0;<year>2021</year>;<volume>53</volume>:<fpage>1379</fpage>&#x02013;<lpage>1389</lpage>.<pub-id pub-id-type="pmid">34548614</pub-id>
</mixed-citation></ref><ref id="cvaf024-B29"><label>29</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Suo</surname> &#x000a0;<given-names>J</given-names></string-name>, <string-name><surname>Ferrara</surname> &#x000a0;<given-names>DE</given-names></string-name>, <string-name><surname>Sorescu</surname> &#x000a0;<given-names>D</given-names></string-name>, <string-name><surname>Guldberg</surname> &#x000a0;<given-names>RE</given-names></string-name>, <string-name><surname>Taylor</surname> &#x000a0;<given-names>WR</given-names></string-name>, <string-name><surname>Giddens</surname> &#x000a0;<given-names>DP</given-names></string-name></person-group>. <article-title>Hemodynamic shear stresses in mouse aortas: implications for atherogenesis</article-title>. <source>Arterioscler Thromb Vasc Biol</source> &#x000a0;<year>2007</year>;<volume>27</volume>:<fpage>346</fpage>&#x02013;<lpage>351</lpage>.<pub-id pub-id-type="pmid">17122449</pub-id>
</mixed-citation></ref><ref id="cvaf024-B30"><label>30</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Li</surname> &#x000a0;<given-names>Z</given-names></string-name>, <string-name><surname>Yang</surname> &#x000a0;<given-names>Z</given-names></string-name>, <string-name><surname>Passaniti</surname> &#x000a0;<given-names>A</given-names></string-name>, <string-name><surname>Lapidus</surname> &#x000a0;<given-names>RG</given-names></string-name>, <string-name><surname>Liu</surname> &#x000a0;<given-names>X</given-names></string-name>, <string-name><surname>Cullen</surname> &#x000a0;<given-names>KJ</given-names></string-name>, <string-name><surname>Dan</surname> &#x000a0;<given-names>HC</given-names></string-name></person-group>. <article-title>A positive feedback loop involving EGFR/Akt/mTORC1 and IKK/NF-kB regulates head and neck squamous cell carcinoma proliferation</article-title>. <source>Oncotarget</source> &#x000a0;<year>2016</year>;<volume>7</volume>:<fpage>31892</fpage>&#x02013;<lpage>31906</lpage>.<pub-id pub-id-type="pmid">26895469</pub-id>
</mixed-citation></ref><ref id="cvaf024-B31"><label>31</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>K&#x000f6;ntgen</surname> &#x000a0;<given-names>F</given-names></string-name>, <string-name><surname>Grumont</surname> &#x000a0;<given-names>RJ</given-names></string-name>, <string-name><surname>Strasser</surname> &#x000a0;<given-names>A</given-names></string-name>, <string-name><surname>Metcalf</surname> &#x000a0;<given-names>D</given-names></string-name>, <string-name><surname>Li</surname> &#x000a0;<given-names>R</given-names></string-name>, <string-name><surname>Tarlinton</surname> &#x000a0;<given-names>D</given-names></string-name>, <string-name><surname>Gerondakis</surname> &#x000a0;<given-names>S</given-names></string-name></person-group>. <article-title>Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression</article-title>. <source>Genes Dev</source> &#x000a0;<year>1995</year>;<volume>9</volume>:<fpage>1965</fpage>&#x02013;<lpage>1977</lpage>.<pub-id pub-id-type="pmid">7649478</pub-id>
</mixed-citation></ref><ref id="cvaf024-B32"><label>32</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Feng</surname> &#x000a0;<given-names>B</given-names></string-name>, <string-name><surname>Cheng</surname> &#x000a0;<given-names>SH</given-names></string-name>, <string-name><surname>Hsia</surname> &#x000a0;<given-names>CY</given-names></string-name>, <string-name><surname>King</surname> &#x000a0;<given-names>LB</given-names></string-name>, <string-name><surname>Monroe</surname> &#x000a0;<given-names>JG</given-names></string-name>, <string-name><surname>Liou</surname> &#x000a0;<given-names>HC</given-names></string-name></person-group>. <article-title>NF-kappa B inducible genes BCL-X and cyclin E promote immature B-cell proliferation and survival</article-title>. <source>Cell Immunol</source> &#x000a0;<year>2004</year>;<volume>232</volume>:<fpage>9</fpage>&#x02013;<lpage>20</lpage>.<pub-id pub-id-type="pmid">15922711</pub-id>
</mixed-citation></ref><ref id="cvaf024-B33"><label>33</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Campbell</surname> &#x000a0;<given-names>IK</given-names></string-name>, <string-name><surname>Gerondakis</surname> &#x000a0;<given-names>S</given-names></string-name>, <string-name><surname>O'Donnell</surname> &#x000a0;<given-names>K</given-names></string-name>, <string-name><surname>Wicks</surname> &#x000a0;<given-names>IP</given-names></string-name></person-group>. <article-title>Distinct roles for the NF-kappaB1 (p50) and c-Rel transcription factors in inflammatory arthritis</article-title>. <source>J Clin Invest</source> &#x000a0;<year>2000</year>;<volume>105</volume>:<fpage>1799</fpage>&#x02013;<lpage>1806</lpage>.<pub-id pub-id-type="pmid">10862795</pub-id>
</mixed-citation></ref><ref id="cvaf024-B34"><label>34</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Gieling</surname> &#x000a0;<given-names>RG</given-names></string-name>, <string-name><surname>Elsharkawy</surname> &#x000a0;<given-names>AM</given-names></string-name>, <string-name><surname>Caamano</surname> &#x000a0;<given-names>JH</given-names></string-name>, <string-name><surname>Cowie</surname> &#x000a0;<given-names>DE</given-names></string-name>, <string-name><surname>Wright</surname> &#x000a0;<given-names>MC</given-names></string-name>, <string-name><surname>Ebrahimkhani</surname> &#x000a0;<given-names>MR</given-names></string-name>, <string-name><surname>Burt</surname> &#x000a0;<given-names>AD</given-names></string-name>, <string-name><surname>Mann</surname> &#x000a0;<given-names>J</given-names></string-name>, <string-name><surname>Raychaudhuri</surname> &#x000a0;<given-names>P</given-names></string-name>, <string-name><surname>Liou</surname> &#x000a0;<given-names>HC</given-names></string-name>, <string-name><surname>Oakley</surname> &#x000a0;<given-names>F</given-names></string-name>, <string-name><surname>Mann</surname> &#x000a0;<given-names>DA</given-names></string-name></person-group>. <article-title>The c-Rel subunit of nuclear factor-kappa B regulates murine liver inflammation, wound-healing, and hepatocyte proliferation</article-title>. <source>Hepatology</source> &#x000a0;<year>2010</year>;<volume>51</volume>:<fpage>922</fpage>&#x02013;<lpage>931</lpage>.<pub-id pub-id-type="pmid">20058312</pub-id>
</mixed-citation></ref><ref id="cvaf024-B35"><label>35</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Gaspar-Pereira</surname> &#x000a0;<given-names>S</given-names></string-name>, <string-name><surname>Fullard</surname> &#x000a0;<given-names>N</given-names></string-name>, <string-name><surname>Townsend</surname> &#x000a0;<given-names>PA</given-names></string-name>, <string-name><surname>Banks</surname> &#x000a0;<given-names>PS</given-names></string-name>, <string-name><surname>Ellis</surname> &#x000a0;<given-names>EL</given-names></string-name>, <string-name><surname>Fox</surname> &#x000a0;<given-names>C</given-names></string-name>, <string-name><surname>Maxwell</surname> &#x000a0;<given-names>AG</given-names></string-name>, <string-name><surname>Murphy</surname> &#x000a0;<given-names>LB</given-names></string-name>, <string-name><surname>Kirk</surname> &#x000a0;<given-names>A</given-names></string-name>, <string-name><surname>Bauer</surname> &#x000a0;<given-names>R</given-names></string-name>, <string-name><surname>Caamano</surname> &#x000a0;<given-names>JH</given-names></string-name>, <string-name><surname>Figg</surname> &#x000a0;<given-names>N</given-names></string-name>, <string-name><surname>Foo</surname> &#x000a0;<given-names>RS</given-names></string-name>, <string-name><surname>Mann</surname> &#x000a0;<given-names>J</given-names></string-name>, <string-name><surname>Mann</surname> &#x000a0;<given-names>DA</given-names></string-name>, <string-name><surname>Oakley</surname> &#x000a0;<given-names>F</given-names></string-name></person-group>. <article-title>The NF-kappa B subunit c-rel stimulates cardiac hypertrophy and fibrosis</article-title>. <source>Am J Pathol</source> &#x000a0;<year>2012</year>;<volume>180</volume>:<fpage>929</fpage>&#x02013;<lpage>939</lpage>.<pub-id pub-id-type="pmid">22210479</pub-id>
</mixed-citation></ref><ref id="cvaf024-B36"><label>36</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Hunter</surname> &#x000a0;<given-names>JE</given-names></string-name>, <string-name><surname>Leslie</surname> &#x000a0;<given-names>J</given-names></string-name>, <string-name><surname>Perkins</surname> &#x000a0;<given-names>ND</given-names></string-name></person-group>. <article-title>c-Rel and its many roles in cancer: an old story with new twists</article-title>. <source>Br J Cancer</source> &#x000a0;<year>2016</year>;<volume>114</volume>:<fpage>1</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="pmid">26757421</pub-id>
</mixed-citation></ref><ref id="cvaf024-B37"><label>37</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Grumont</surname> &#x000a0;<given-names>RJ</given-names></string-name>, <string-name><surname>Strasser</surname> &#x000a0;<given-names>A</given-names></string-name>, <string-name><surname>Gerondakis</surname> &#x000a0;<given-names>S</given-names></string-name></person-group>. <article-title>B cell growth is controlled by phosphatidylinosotol 3-kinase-dependent induction of Rel/NF-&#x003ba;B regulated c-myc transcription</article-title>. <source>Mol Cell</source> &#x000a0;<year>2002</year>;<volume>10</volume>:<fpage>1283</fpage>&#x02013;<lpage>1294</lpage>.<pub-id pub-id-type="pmid">12504005</pub-id>
</mixed-citation></ref><ref id="cvaf024-B38"><label>38</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>S&#x000e1;nchez-Valdepe&#x000f1;as</surname> &#x000a0;<given-names>C</given-names></string-name>, <string-name><surname>Punz&#x000f3;n</surname> &#x000a0;<given-names>C</given-names></string-name>, <string-name><surname>San-Antonio</surname> &#x000a0;<given-names>B</given-names></string-name>, <string-name><surname>Martin</surname> &#x000a0;<given-names>AG</given-names></string-name>, <string-name><surname>Fresno</surname> &#x000a0;<given-names>M</given-names></string-name></person-group>. <article-title>Differential regulation of p65 and c-Rel NF-kappaB transactivating activity by Cot, protein kinase C zeta and NIK protein kinases in CD3/CD28 activated T cells</article-title>. <source>Cell Signal</source> &#x000a0;<year>2007</year>;<volume>19</volume>:<fpage>528</fpage>&#x02013;<lpage>537</lpage>.<pub-id pub-id-type="pmid">17070014</pub-id>
</mixed-citation></ref><ref id="cvaf024-B39"><label>39</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Yamawaki</surname> &#x000a0;<given-names>H</given-names></string-name>, <string-name><surname>Pan</surname> &#x000a0;<given-names>S</given-names></string-name>, <string-name><surname>Lee</surname> &#x000a0;<given-names>RT</given-names></string-name>, <string-name><surname>Berk</surname> &#x000a0;<given-names>BC</given-names></string-name></person-group>. <article-title>Fluid shear stress inhibits vascular inflammation by decreasing thioredoxin-interacting protein in endothelial cells</article-title>. <source>J Clin Invest</source> &#x000a0;<year>2005</year>;<volume>115</volume>:<fpage>733</fpage>&#x02013;<lpage>738</lpage>.<pub-id pub-id-type="pmid">15696199</pub-id>
</mixed-citation></ref><ref id="cvaf024-B40"><label>40</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Yao</surname> &#x000a0;<given-names>Z</given-names></string-name>, <string-name><surname>Xing</surname> &#x000a0;<given-names>L</given-names></string-name>, <string-name><surname>Boyce</surname> &#x000a0;<given-names>BF</given-names></string-name></person-group>. <article-title>NF-kappaB p100 limits TNF-induced bone resorption in mice by a TRAF3-dependent mechanism</article-title>. <source>J Clin Invest</source> &#x000a0;<year>2009</year>;<volume>119</volume>:<fpage>3024</fpage>&#x02013;<lpage>3034</lpage>.<pub-id pub-id-type="pmid">19770515</pub-id>
</mixed-citation></ref><ref id="cvaf024-B41"><label>41</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Matsumoto</surname> &#x000a0;<given-names>M</given-names></string-name>, <string-name><surname>Sudo</surname> &#x000a0;<given-names>T</given-names></string-name>, <string-name><surname>Saito</surname> &#x000a0;<given-names>T</given-names></string-name>, <string-name><surname>Osada</surname> &#x000a0;<given-names>H</given-names></string-name>, <string-name><surname>Tsujimoto</surname> &#x000a0;<given-names>M</given-names></string-name></person-group>. <article-title>Involvement of p38 mitogen-activated protein kinase signaling pathway in osteoclastogenesis mediated by receptor activator of NF-kappa B ligand (RANKL)</article-title>. <source>J Biol Chem</source> &#x000a0;<year>2000</year>;<volume>275</volume>:<fpage>31155</fpage>&#x02013;<lpage>31161</lpage>.<pub-id pub-id-type="pmid">10859303</pub-id>
</mixed-citation></ref><ref id="cvaf024-B42"><label>42</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Min</surname> &#x000a0;<given-names>JK</given-names></string-name>, <string-name><surname>Kim</surname> &#x000a0;<given-names>YM</given-names></string-name>, <string-name><surname>Kim</surname> &#x000a0;<given-names>YM</given-names></string-name>, <string-name><surname>Kim</surname> &#x000a0;<given-names>EC</given-names></string-name>, <string-name><surname>Gho</surname> &#x000a0;<given-names>YS</given-names></string-name>, <string-name><surname>Kang</surname> &#x000a0;<given-names>IJ</given-names></string-name>, <string-name><surname>Lee</surname> &#x000a0;<given-names>SY</given-names></string-name>, <string-name><surname>Kong</surname> &#x000a0;<given-names>YY</given-names></string-name>, <string-name><surname>Kwon</surname> &#x000a0;<given-names>YG</given-names></string-name></person-group>. <article-title>Vascular endothelial growth factor up-regulates expression of receptor activator of NF-kappa B (RANK) in endothelial cells. Concomitant increase of angiogenic responses to RANK ligand</article-title>. <source>J Biol Chem</source> &#x000a0;<year>2003</year>;<volume>278</volume>:<fpage>39548</fpage>&#x02013;<lpage>39557</lpage>.<pub-id pub-id-type="pmid">12893832</pub-id>
</mixed-citation></ref><ref id="cvaf024-B43"><label>43</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Zhang</surname> &#x000a0;<given-names>L</given-names></string-name>, <string-name><surname>Lin</surname> &#x000a0;<given-names>K</given-names></string-name>, <string-name><surname>Wang</surname> &#x000a0;<given-names>Y</given-names></string-name>, <string-name><surname>Yu</surname> &#x000a0;<given-names>H</given-names></string-name>, <string-name><surname>Li</surname> &#x000a0;<given-names>J</given-names></string-name>, <string-name><surname>Fu</surname> &#x000a0;<given-names>L</given-names></string-name>, <string-name><surname>Xu</surname> &#x000a0;<given-names>Y</given-names></string-name>, <string-name><surname>Wei</surname> &#x000a0;<given-names>B</given-names></string-name>, <string-name><surname>Mai</surname> &#x000a0;<given-names>H</given-names></string-name>, <string-name><surname>Jiang</surname> &#x000a0;<given-names>Z</given-names></string-name>, <string-name><surname>Che</surname> &#x000a0;<given-names>D</given-names></string-name>, <string-name><surname>Pi</surname> &#x000a0;<given-names>L</given-names></string-name>, <string-name><surname>Gu</surname> &#x000a0;<given-names>X</given-names></string-name></person-group>. <article-title>Protective effect of TNFRSF11A rs7239667 G &#x0003e; C gene polymorphism on coronary outcome of Kawasaki disease in southern Chinese population</article-title>. <source>Front Genet</source> &#x000a0;<year>2021</year>;<volume>12</volume>:<fpage>691282</fpage>.<pub-id pub-id-type="pmid">34484292</pub-id>
</mixed-citation></ref><ref id="cvaf024-B44"><label>44</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Schumm</surname> &#x000a0;<given-names>K</given-names></string-name>, <string-name><surname>Rocha</surname> &#x000a0;<given-names>S</given-names></string-name>, <string-name><surname>Caamano</surname> &#x000a0;<given-names>J</given-names></string-name>, <string-name><surname>Perkins</surname> &#x000a0;<given-names>ND</given-names></string-name></person-group>. <article-title>Regulation of p53 tumour suppressor target gene expression by the p52 NF-kappa B subunit</article-title>. <source>EMBO J</source> &#x000a0;<year>2006</year>;<volume>25</volume>:<fpage>4820</fpage>&#x02013;<lpage>4832</lpage>.<pub-id pub-id-type="pmid">16990795</pub-id>
</mixed-citation></ref><ref id="cvaf024-B45"><label>45</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Yan</surname> &#x000a0;<given-names>J</given-names></string-name>, <string-name><surname>Chen</surname> &#x000a0;<given-names>S</given-names></string-name>, <string-name><surname>Yi</surname> &#x000a0;<given-names>Z</given-names></string-name>, <string-name><surname>Zhao</surname> &#x000a0;<given-names>R</given-names></string-name>, <string-name><surname>Zhu</surname> &#x000a0;<given-names>J</given-names></string-name>, <string-name><surname>Ding</surname> &#x000a0;<given-names>S</given-names></string-name>, <string-name><surname>Wu</surname> &#x000a0;<given-names>J</given-names></string-name></person-group>. <article-title>The role of p21 in cellular senescence and aging-related diseases</article-title>. <source>Mol Cells</source> &#x000a0;<year>2024</year>:<volume>47</volume>(<issue>1</issue>):<fpage>100113</fpage>.<pub-id pub-id-type="pmid">39304134</pub-id>
</mixed-citation></ref><ref id="cvaf024-B46"><label>46</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Sun</surname> &#x000a0;<given-names>Y</given-names></string-name>, <string-name><surname>Rawish</surname> &#x000a0;<given-names>E</given-names></string-name>, <string-name><surname>Nording</surname> &#x000a0;<given-names>HM</given-names></string-name>, <string-name><surname>Langer</surname> &#x000a0;<given-names>HF</given-names></string-name></person-group>. <article-title>Inflammation in metabolic and cardiovascular disorders-role of oxidative stress</article-title>. <source>Life (Basel)</source> &#x000a0;<year>2021</year>;<volume>11</volume>:<fpage>672</fpage>.<pub-id pub-id-type="pmid">34357044</pub-id>
</mixed-citation></ref><ref id="cvaf024-B47"><label>47</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Feng</surname> &#x000a0;<given-names>S</given-names></string-name>, <string-name><surname>Bowden</surname> &#x000a0;<given-names>N</given-names></string-name>, <string-name><surname>Fragiadaki</surname> &#x000a0;<given-names>M</given-names></string-name>, <string-name><surname>Souilhol</surname> &#x000a0;<given-names>C</given-names></string-name>, <string-name><surname>Hsiao</surname> &#x000a0;<given-names>S</given-names></string-name>, <string-name><surname>Mahmoud</surname> &#x000a0;<given-names>M</given-names></string-name>, <string-name><surname>Allen</surname> &#x000a0;<given-names>S</given-names></string-name>, <string-name><surname>Pirri</surname> &#x000a0;<given-names>D</given-names></string-name>, <string-name><surname>Ayllon</surname> &#x000a0;<given-names>BT</given-names></string-name>, <string-name><surname>Akhtar</surname> &#x000a0;<given-names>S</given-names></string-name>, <string-name><surname>Thompson</surname> &#x000a0;<given-names>AAR</given-names></string-name>, <string-name><surname>Jo</surname> &#x000a0;<given-names>H</given-names></string-name>, <string-name><surname>Weber</surname> &#x000a0;<given-names>C</given-names></string-name>, <string-name><surname>Ridger</surname> &#x000a0;<given-names>V</given-names></string-name>, <string-name><surname>Schober</surname> &#x000a0;<given-names>A</given-names></string-name>, <string-name><surname>Evans</surname> &#x000a0;<given-names>PC</given-names></string-name></person-group>. <article-title>Mechanical activation of hypoxia-inducible factor 1 alpha drives endothelial dysfunction at atheroprone sites</article-title>. <source>Arterioscler Thromb Vasc Biol</source> &#x000a0;<year>2017</year>;<volume>37</volume>:<fpage>2087</fpage>&#x02013;<lpage>2101</lpage>.<pub-id pub-id-type="pmid">28882872</pub-id>
</mixed-citation></ref><ref id="cvaf024-B48"><label>48</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>L&#x000e9;vy</surname> &#x000a0;<given-names>R</given-names></string-name>, <string-name><surname>Langlais</surname> &#x000a0;<given-names>D</given-names></string-name>, <string-name><surname>B&#x000e9;ziat</surname> &#x000a0;<given-names>V</given-names></string-name>, <string-name><surname>Rapaport</surname> &#x000a0;<given-names>F</given-names></string-name>, <string-name><surname>Rao</surname> &#x000a0;<given-names>G</given-names></string-name>, <string-name><surname>Lazarov</surname> &#x000a0;<given-names>T</given-names></string-name>, <string-name><surname>Bourgey</surname> &#x000a0;<given-names>M</given-names></string-name>, <string-name><surname>Zhou</surname> &#x000a0;<given-names>YJ</given-names></string-name>, <string-name><surname>Briand</surname> &#x000a0;<given-names>C</given-names></string-name>, <string-name><surname>Moriya</surname> &#x000a0;<given-names>K</given-names></string-name>, <string-name><surname>Ailal</surname> &#x000a0;<given-names>F</given-names></string-name>, <string-name><surname>Avery</surname> &#x000a0;<given-names>DT</given-names></string-name>, <string-name><surname>Markle</surname> &#x000a0;<given-names>J</given-names></string-name>, <string-name><surname>Lim</surname> &#x000a0;<given-names>AI</given-names></string-name>, <string-name><surname>Ogishi</surname> &#x000a0;<given-names>M</given-names></string-name>, <string-name><surname>Yang</surname> &#x000a0;<given-names>R</given-names></string-name>, <string-name><surname>Pelham</surname> &#x000a0;<given-names>S</given-names></string-name>, <string-name><surname>Emam</surname> &#x000a0;<given-names>M</given-names></string-name>, <string-name><surname>Migaud</surname> &#x000a0;<given-names>M</given-names></string-name>, <string-name><surname>Deswarte</surname> &#x000a0;<given-names>C</given-names></string-name>, <string-name><surname>Habib</surname> &#x000a0;<given-names>T</given-names></string-name>, <string-name><surname>Saraiva</surname> &#x000a0;<given-names>LR</given-names></string-name>, <string-name><surname>Moussa</surname> &#x000a0;<given-names>EA</given-names></string-name>, <string-name><surname>Guennoun</surname> &#x000a0;<given-names>A</given-names></string-name>, <string-name><surname>Boisson</surname> &#x000a0;<given-names>B</given-names></string-name>, <string-name><surname>Belkaya</surname> &#x000a0;<given-names>S</given-names></string-name>, <string-name><surname>Martinez-Barricarte</surname> &#x000a0;<given-names>R</given-names></string-name>, <string-name><surname>Rosain</surname> &#x000a0;<given-names>J</given-names></string-name>, <string-name><surname>Belkadi</surname> &#x000a0;<given-names>A</given-names></string-name>, <string-name><surname>Breton</surname> &#x000a0;<given-names>S</given-names></string-name>, <string-name><surname>Payne</surname> &#x000a0;<given-names>K</given-names></string-name>, <string-name><surname>Benhsaien</surname> &#x000a0;<given-names>I</given-names></string-name>, <string-name><surname>Plebani</surname> &#x000a0;<given-names>A</given-names></string-name>, <string-name><surname>Lougaris</surname> &#x000a0;<given-names>V</given-names></string-name>, <string-name><surname>Di Santo</surname> &#x000a0;<given-names>JP</given-names></string-name>, <string-name><surname>Neven</surname> &#x000a0;<given-names>B</given-names></string-name>, <string-name><surname>Abel</surname> &#x000a0;<given-names>L</given-names></string-name>, <string-name><surname>Ma</surname> &#x000a0;<given-names>CS</given-names></string-name>, <string-name><surname>Bousfiha</surname> &#x000a0;<given-names>AA</given-names></string-name>, <string-name><surname>Marr</surname> &#x000a0;<given-names>N</given-names></string-name>, <string-name><surname>Bustamante</surname> &#x000a0;<given-names>J</given-names></string-name>, <string-name><surname>Liu</surname> &#x000a0;<given-names>K</given-names></string-name>, <string-name><surname>Gros</surname> &#x000a0;<given-names>P</given-names></string-name>, <string-name><surname>Geissmann</surname> &#x000a0;<given-names>F</given-names></string-name>, <string-name><surname>Tangye</surname> &#x000a0;<given-names>SG</given-names></string-name>, <string-name><surname>Casanova</surname> &#x000a0;<given-names>JL</given-names></string-name>, <string-name><surname>Puel</surname> &#x000a0;<given-names>A</given-names></string-name></person-group>. <article-title>Inherited human c-Rel deficiency disrupts myeloid and lymphoid immunity to multiple infectious agents</article-title>. <source>J Clin Invest</source> &#x000a0;<year>2021</year>;<volume>131</volume>:<fpage>e150143</fpage>.<pub-id pub-id-type="pmid">34623332</pub-id>
</mixed-citation></ref><ref id="cvaf024-B49"><label>49</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Leslie</surname> &#x000a0;<given-names>J</given-names></string-name>, <string-name><surname>Macia</surname> &#x000a0;<given-names>MG</given-names></string-name>, <string-name><surname>Luli</surname> &#x000a0;<given-names>S</given-names></string-name>, <string-name><surname>Worrell</surname> &#x000a0;<given-names>JC</given-names></string-name>, <string-name><surname>Reilly</surname> &#x000a0;<given-names>WJ</given-names></string-name>, <string-name><surname>Paish</surname> &#x000a0;<given-names>HL</given-names></string-name>, <string-name><surname>Knox</surname> &#x000a0;<given-names>A</given-names></string-name>, <string-name><surname>Barksby</surname> &#x000a0;<given-names>BS</given-names></string-name>, <string-name><surname>Gee</surname> &#x000a0;<given-names>LM</given-names></string-name>, <string-name><surname>Zaki</surname> &#x000a0;<given-names>MYW</given-names></string-name>, <string-name><surname>Collins</surname> &#x000a0;<given-names>AL</given-names></string-name>, <string-name><surname>Burgoyne</surname> &#x000a0;<given-names>RA</given-names></string-name>, <string-name><surname>Cameron</surname> &#x000a0;<given-names>R</given-names></string-name>, <string-name><surname>Bragg</surname> &#x000a0;<given-names>C</given-names></string-name>, <string-name><surname>Xu</surname> &#x000a0;<given-names>X</given-names></string-name>, <string-name><surname>Chung</surname> &#x000a0;<given-names>GW</given-names></string-name>, <string-name><surname>Brown</surname> &#x000a0;<given-names>CDA</given-names></string-name>, <string-name><surname>Blanchard</surname> &#x000a0;<given-names>AD</given-names></string-name>, <string-name><surname>Nanthakumar</surname> &#x000a0;<given-names>CB</given-names></string-name>, <string-name><surname>Karsdal</surname> &#x000a0;<given-names>M</given-names></string-name>, <string-name><surname>Robinson</surname> &#x000a0;<given-names>SM</given-names></string-name>, <string-name><surname>Manas</surname> &#x000a0;<given-names>DM</given-names></string-name>, <string-name><surname>Sen</surname> &#x000a0;<given-names>G</given-names></string-name>, <string-name><surname>French</surname> &#x000a0;<given-names>J</given-names></string-name>, <string-name><surname>White</surname> &#x000a0;<given-names>SA</given-names></string-name>, <string-name><surname>Murphy</surname> &#x000a0;<given-names>S</given-names></string-name>, <string-name><surname>Trost</surname> &#x000a0;<given-names>M</given-names></string-name>, <string-name><surname>Zakrzewski</surname> &#x000a0;<given-names>JL</given-names></string-name>, <string-name><surname>Klein</surname> &#x000a0;<given-names>U</given-names></string-name>, <string-name><surname>Schwabe</surname> &#x000a0;<given-names>RF</given-names></string-name>, <string-name><surname>Mederacke</surname> &#x000a0;<given-names>I</given-names></string-name>, <string-name><surname>Nixon</surname> &#x000a0;<given-names>C</given-names></string-name>, <string-name><surname>Bird</surname> &#x000a0;<given-names>T</given-names></string-name>, <string-name><surname>Teuwen</surname> &#x000a0;<given-names>LA</given-names></string-name>, <string-name><surname>Schoonjans</surname> &#x000a0;<given-names>L</given-names></string-name>, <string-name><surname>Carmeliet</surname> &#x000a0;<given-names>P</given-names></string-name>, <string-name><surname>Mann</surname> &#x000a0;<given-names>J</given-names></string-name>, <string-name><surname>Fisher</surname> &#x000a0;<given-names>AJ</given-names></string-name>, <string-name><surname>Sheerin</surname> &#x000a0;<given-names>NS</given-names></string-name>, <string-name><surname>Borthwick</surname> &#x000a0;<given-names>LA</given-names></string-name>, <string-name><surname>Mann</surname> &#x000a0;<given-names>DA</given-names></string-name>, <string-name><surname>Oakley</surname> &#x000a0;<given-names>F</given-names></string-name></person-group>. <article-title>c-Rel orchestrates energy-dependent epithelial and macrophage reprogramming in fibrosis</article-title>. <source>Nat Metab</source> &#x000a0;<year>2020</year>;<volume>2</volume>:<fpage>1350</fpage>&#x02013;<lpage>1367</lpage>.<pub-id pub-id-type="pmid">33168981</pub-id>
</mixed-citation></ref><ref id="cvaf024-B50"><label>50</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Heida</surname> &#x000a0;<given-names>A</given-names></string-name>, <string-name><surname>Gruben</surname> &#x000a0;<given-names>N</given-names></string-name>, <string-name><surname>Catrysse</surname> &#x000a0;<given-names>L</given-names></string-name>, <string-name><surname>Koehorst</surname> &#x000a0;<given-names>M</given-names></string-name>, <string-name><surname>Koster</surname> &#x000a0;<given-names>M</given-names></string-name>, <string-name><surname>Kloosterhuis</surname> &#x000a0;<given-names>NJ</given-names></string-name>, <string-name><surname>Gerding</surname> &#x000a0;<given-names>A</given-names></string-name>, <string-name><surname>Havinga</surname> &#x000a0;<given-names>R</given-names></string-name>, <string-name><surname>Bloks</surname> &#x000a0;<given-names>VW</given-names></string-name>, <string-name><surname>Bongiovanni</surname> &#x000a0;<given-names>L</given-names></string-name>, <string-name><surname>Wolters</surname> &#x000a0;<given-names>JC</given-names></string-name>, <string-name><surname>van Dijk</surname> &#x000a0;<given-names>T</given-names></string-name>, <string-name><surname>van Loo</surname> &#x000a0;<given-names>G</given-names></string-name>, <string-name><surname>de Bruin</surname> &#x000a0;<given-names>A</given-names></string-name>, <string-name><surname>Kuipers</surname> &#x000a0;<given-names>F</given-names></string-name>, <string-name><surname>Koonen</surname> &#x000a0;<given-names>DPY</given-names></string-name>, <string-name><surname>van de Sluis</surname> &#x000a0;<given-names>B</given-names></string-name></person-group>. <article-title>The hepatocyte IKK:NF-&#x003ba;B axis promotes liver steatosis by stimulating de novo lipogenesis and cholesterol synthesis</article-title>. <source>Mol Metab</source> &#x000a0;<year>2021</year>;<volume>54</volume>:<fpage>101349</fpage>.<pub-id pub-id-type="pmid">34626855</pub-id>
</mixed-citation></ref></ref-list></back></article>